Created : Thu 11-Jul-2019 07:54:33	This file is subject to change without notice.
Pre-filtered for US companies over $5 and average trading volume of at least 100K.

List of tickers with Cash from Operations less than Working Capital deficit.
 CATS OSTK

List of tickers with Current Ratio < 1.00 and paying more than 15.0% of Sales to Interest.
 CATS

List of tickers with FCF + Working Capital less than 0.
*Paid a dividend -- may need to cut dividend.
 NVAX OMER MDCO LXRX PTLA MDR JACK* MLNT CLVS PZZA* SPWR REV TGTX AAL* ATNX TDW* QCOM*
 CATS OSTK IRWD MAT* NTRA GLIBA* YUM* CVNA

List of tickers with negative Cash from Ops and Cash Flow with no Shareholder Equity.
 NVAX MDCO SPWR IRWD REPH

List of tickers with big buybacks and an available cash flow deficit.
 JACK QCOM YUM

Seq : this quarter versus last quarter.
QoQ : this quarter versus same quarter a year ago.
YoY : last 12m versus 12m a year ago.

--------------------------

Rank : 1
 CLXT
	Calyxt Inc : ROSEVILLE, MN
	Non-Cyclicals, Fishing & Farming
	Employees     :           50
	OpInc per Emp : $ -1,946,000
	10Q Date      :  31-Mar-2019

	Market Cap        :        348.42 M
	Shares            :         32.68 M (Seq=    0.21% : QoQ=   17.33%)

	Sales 12m         :          1.50 M (Seq=  100.00% : QoQ=  -69.23%)
	Ops Income 12m    :        -97.30 M (Seq=  -11.39% : QoQ= -439.66%)
	Net Income 12m    :        -96.90 M (Seq=  -10.75% : QoQ= -423.73%)
	Interest Paid 12m :          2.70 M (Seq=    7.69% : QoQ=  366.67%)

	Cash <- Ops 12m   :        -23.10 M (Seq=  -38.81% : QoQ=  -40.91%)
	  CapEx 12m       :          2.10 M (Seq=  -70.00% : QoQ=    0.00%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :        -25.20 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :         60.10 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :         37.00 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :         -2.10 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :         34.90 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :         87.00 M (Seq=   -8.90% : QoQ=   64.77%)
	  Cash            :         84.20 M (Seq=  -10.23% : QoQ=   66.07%)
	  Acct Rx         :          0.30 M (Seq=    0.00% : QoQ=    0.00%)
	  ST Invest       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Inventory       :          0.40 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :          2.20 M (Seq=   29.41% : QoQ=    4.76%)
	Current Liabs     :          4.70 M (Seq=  -32.86% : QoQ=   56.67%)
	  Acct Pay        :          0.70 M (Seq=  -12.50% : QoQ=   75.00%)
	  ST Debt         :          0.30 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :          3.70 M (Seq=  -37.29% : QoQ=   48.00%)
	Working Capital   :         82.30 M (Ratio=18.51)
	WC + FCF          :         57.10 M

	Sharehldr Equity  :         87.70 M (Seq=   -6.10% : QoQ=   62.71%)
	Tangible Assets   :        110.70 M (Seq=   -6.82% : QoQ=   53.96%)
	LT Debt           :         18.20 M (Seq=    0.00% : QoQ=   22.97%)
	LT Debt to Equity :          0.21

	Last Price          :       10.93 : (52wkHi= 19.30 %offHigh=43%)
	PE                  :      275.00
	Op Margin           :   -6,486.67%
	Net Margin          :   -6,460.00%
	ROE                 :     -110.49%
	Interest % of sales :      180.00%
	Q0 Est Growth       :     -244.59%
	Y1 Est Growth       :      -53.14%

	CLXT State -->
	  Interest payments to sales is high at 180.00%.

	Zombie Score : 140.00
		Negative Sales        :   35.00
		Margins               :   35.00
		Available Cash to MC  :    0.00
		Interest Paid         :   35.00
		LT Debt to Equity     :    0.00
		Equity to MC          :  -10.00
		OpsInc Growth 3Yr     :   35.00 : (-69.10%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00
		Earnings weakness     :   10.00

Rank : 2
 NVAX
	Novavax, Inc. : GAITHERSBURG, MD
	Healthcare, Biotechnology & Medical Research
	Employees     :          379
	OpInc per Emp : $ -2,072,031
	10Q Date      :  31-Mar-2019

	Market Cap        :         99.42 M
	Shares            :         20.44 M (Seq=    6.66% : QoQ=   21.32%)

	Sales 12m         :        109.50 M (Seq=  -16.62% : QoQ=  -21.21%)
	Ops Income 12m    :       -785.30 M (Seq=    1.90% : QoQ=   -8.52%)
	Net Income 12m    :       -830.10 M (Seq=    1.68% : QoQ=  -15.74%)
	Interest Paid 12m :         54.30 M (Seq=    0.00% : QoQ= 6,700.00%)

	Cash <- Ops 12m   :       -169.40 M (Seq=  -11.70% : QoQ=   23.45%)
	  CapEx 12m       :          2.00 M (Seq=   60.00% : QoQ=  300.00%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :       -171.40 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :        115.10 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :        -54.30 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :         26.70 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :        -27.60 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        123.40 M (Seq=    3.44% : QoQ=  -31.82%)
	  Cash            :         97.70 M (Seq=   39.17% : QoQ=  -13.84%)
	  Acct Rx         :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  ST Invest       :          2.50 M (Seq=  -88.64% : QoQ=  -91.78%)
	  Inventory       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :         23.20 M (Seq=  -14.39% : QoQ=  -37.80%)
	Current Liabs     :         31.50 M (Seq=  -30.77% : QoQ=  -29.84%)
	  Acct Pay        :          6.20 M (Seq=  -33.33% : QoQ=    6.90%)
	  ST Debt         :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :         25.30 M (Seq=  -30.11% : QoQ=  -35.29%)
	Working Capital   :         91.90 M (Ratio=3.92)
	WC + FCF          :        -79.50 M

	Sharehldr Equity  :       -150.60 M (Seq=   10.30% : QoQ=  -51.51%)
	Tangible Assets   :        163.90 M (Seq=    9.63% : QoQ=  -23.84%)
	LT Debt           :        319.50 M (Seq=    0.09% : QoQ=    0.44%)
	LT Debt Tan Asset :          1.95

	Last Price          :        5.13 : (52wkHi= 51.60 %offHigh=90%)
	PE                  :      275.00
	Op Margin           :     -717.17%
	Net Margin          :     -758.08%
	ROE                 :        0.00%
	Interest % of sales :       49.59%
	Q0 Est Growth       :      124.43%
	Y1 Est Growth       :      117.38%

	NVAX State -->
	  Free Cash Flow plus Working Capital is negative (-79.50)
	  Running company with Financing. Cash from Financing greater than FCF plus Working Capital.
	  Interest payments to sales is high at 49.59%.
	  Shareholders have no equity.

	Zombie Score : 129.61
		Negative Sales        :   21.21
		Margins               :   35.00
		Available Cash to MC  :   35.00
		Interest Paid         :   35.00
		LT Debt to Equity     :    5.00
		Equity to MC          :   30.00
		OpsInc Growth 3Yr     :    3.40 : (-3.40%)
		Share Decline         :    0.00
		Price                 :  -35.00
		Price % of 52wk High  :    0.00

Rank : 3
 RETA
	Reata Pharmaceuticals Inc : IRVING, TX
	Healthcare, Biotechnology & Medical Research
	Employees     :          123
	OpInc per Emp : $ -1,969,918
	10Q Date      :  31-Mar-2019

	Market Cap        :      2,560.34 M
	Shares            :         29.83 M (Seq=    0.30% : QoQ=   14.05%)

	Sales 12m         :        180.60 M (Seq=  -45.90% : QoQ=  -42.35%)
	Ops Income 12m    :       -242.30 M (Seq=  -41.98% : QoQ= -36,766.67%)
	Net Income 12m    :       -248.20 M (Seq=  -41.37% : QoQ= -7,486.67%)
	Interest Paid 12m :         15.80 M (Seq=   30.65% : QoQ=    0.00%)

	Cash <- Ops 12m   :        -88.50 M (Seq=   23.47% : QoQ=  -19.58%)
	  CapEx 12m       :          1.70 M (Seq=  300.00% : QoQ=  500.00%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :        -90.20 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :        297.40 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :        208.90 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :         -1.70 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :        207.20 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        317.50 M (Seq=   -7.25% : QoQ=  135.71%)
	  Cash            :        313.10 M (Seq=   -7.31% : QoQ=  195.66%)
	  Acct Rx         :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  ST Invest       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Inventory       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :          4.40 M (Seq=   -2.22% : QoQ=   76.00%)
	Current Liabs     :         61.20 M (Seq=    9.48% : QoQ=   19.07%)
	  Acct Pay        :          3.50 M (Seq=  -22.22% : QoQ=  250.00%)
	  ST Debt         :          0.00 M (Seq=    0.00% : QoQ= -100.00%)
	  Other           :         57.70 M (Seq=   12.26% : QoQ=   20.96%)
	Working Capital   :        256.30 M (Ratio=5.19)
	WC + FCF          :        166.10 M

	Sharehldr Equity  :         -4.60 M (Seq= -130.26% : QoQ=   96.78%)
	Tangible Assets   :        331.30 M (Seq=   -4.03% : QoQ=  142.18%)
	LT Debt           :         79.60 M (Seq=    0.51% : QoQ=  368.24%)
	LT Debt Tan Asset :          0.24

	Last Price          :       89.48 : (52wkHi= 104.53 %offHigh=14%)
	PE                  :      275.00
	Op Margin           :     -134.16%
	Net Margin          :     -137.43%
	ROE                 :        0.00%
	Interest % of sales :        8.75%
	Q0 Est Growth       :     -300.00%
	Y1 Est Growth       :     -183.01%

	RETA State -->
	  Shareholders have no equity.

	Zombie Score : 121.09
		Negative Sales        :   35.00
		Margins               :   27.16
		Available Cash to MC  :    0.00
		Interest Paid         :    8.75
		LT Debt to Equity     :    5.00
		Equity to MC          :    0.18
		OpsInc Growth 3Yr     :   35.00 : (-515.50%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00
		Earnings weakness     :   10.00

Rank : 4
 OMER
	Omeros Corporation : SEATTLE, WA
	Healthcare, Biotechnology & Medical Research
	Employees     :          236
	OpInc per Emp : $ -1,464,830
	10Q Date      :  31-Mar-2019

	Market Cap        :        741.73 M
	Shares            :         49.01 M (Seq=   -0.01% : QoQ=    1.51%)

	Sales 12m         :        186.40 M (Seq=   67.56% : QoQ=  271.11%)
	Ops Income 12m    :       -345.70 M (Seq=    6.79% : QoQ=  -60.74%)
	Net Income 12m    :       -368.00 M (Seq=    4.57% : QoQ=  -61.12%)
	Interest Paid 12m :         54.10 M (Seq=   16.56% : QoQ=  427.78%)

	Cash <- Ops 12m   :       -105.40 M (Seq=   47.77% : QoQ=  -14.16%)
	  CapEx 12m       :          0.60 M (Seq=  100.00% : QoQ=    0.00%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :       -106.00 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :         80.40 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :        -25.00 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :         27.90 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :          2.90 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :         76.90 M (Seq=  -14.46% : QoQ=   -2.29%)
	  Cash            :          4.10 M (Seq=  -30.51% : QoQ=  241.67%)
	  Acct Rx         :         24.70 M (Seq=    8.33% : QoQ= 12,250.00%)
	  ST Invest       :         43.20 M (Seq=  -20.88% : QoQ=  -39.66%)
	  Inventory       :          0.70 M (Seq=  600.00% : QoQ=  250.00%)
	  Other           :          4.20 M (Seq=  -35.38% : QoQ=  -22.22%)
	Current Liabs     :         44.50 M (Seq=   18.98% : QoQ=   80.89%)
	  Acct Pay        :          7.10 M (Seq=   12.70% : QoQ=  -30.39%)
	  ST Debt         :          1.10 M (Seq=   22.22% : QoQ=  120.00%)
	  Other           :         36.20 M (Seq=   19.87% : QoQ=  160.43%)
	Working Capital   :         32.40 M (Ratio=1.73)
	WC + FCF          :        -73.60 M

	Sharehldr Equity  :       -121.00 M (Seq=  -20.76% : QoQ= -314.38%)
	Tangible Assets   :        101.20 M (Seq=    5.53% : QoQ=   13.71%)
	LT Debt           :        153.10 M (Seq=    1.66% : QoQ=   80.12%)
	LT Debt Tan Asset :          1.51

	Last Price          :       15.21 : (52wkHi= 27.00 %offHigh=43%)
	PE                  :      275.00
	Op Margin           :     -185.46%
	Net Margin          :     -197.42%
	ROE                 :        0.00%
	Interest % of sales :       29.02%
	Q0 Est Growth       :      101.29%
	Y1 Est Growth       :      124.07%

	OMER State -->
	  Free Cash Flow plus Working Capital is negative (-73.60)
	  Running company with Financing. Cash from Financing greater than FCF plus Working Capital.
	  Interest payments to sales is high at 29.02%.
	  Shareholders have no equity.

	Zombie Score : 115.18
		Negative Sales        :    0.00
		Margins               :   35.00
		Available Cash to MC  :    9.84
		Interest Paid         :   29.02
		LT Debt to Equity     :    5.00
		Equity to MC          :   16.31
		OpsInc Growth 3Yr     :   20.00 : (-20.00%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00

Rank : 5
 FLXN
	Flexion Therapeutics Inc : BURLINGTON, MA
	Healthcare, Biotechnology & Medical Research
	Employees     :          272
	OpInc per Emp : $ -1,903,676
	10Q Date      :  31-Mar-2019

	Market Cap        :        421.20 M
	Shares            :         37.99 M (Seq=    0.33% : QoQ=    0.99%)

	Sales 12m         :         53.80 M (Seq=   37.33% : QoQ=    0.00%)
	Ops Income 12m    :       -517.80 M (Seq=    0.06% : QoQ= -245.12%)
	Net Income 12m    :       -548.70 M (Seq=    0.06% : QoQ= -266.31%)
	Interest Paid 12m :         44.40 M (Seq=    0.00% : QoQ= 2,516.67%)

	Cash <- Ops 12m   :       -153.40 M (Seq=   11.01% : QoQ=   15.56%)
	  CapEx 12m       :          1.60 M (Seq=  450.00% : QoQ=  266.67%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :       -155.00 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :         -6.80 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :       -160.20 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :        100.20 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :        -60.00 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        248.00 M (Seq=  -12.98% : QoQ=  -34.84%)
	  Cash            :         87.90 M (Seq=    0.80% : QoQ=  -40.33%)
	  Acct Rx         :         15.60 M (Seq=   13.04% : QoQ=  403.23%)
	  ST Invest       :        129.90 M (Seq=  -24.30% : QoQ=  -42.09%)
	  Inventory       :         10.30 M (Seq=   35.53% : QoQ=  312.00%)
	  Other           :          4.10 M (Seq=  -14.58% : QoQ=   20.59%)
	Current Liabs     :         39.20 M (Seq=    7.10% : QoQ=   60.66%)
	  Acct Pay        :         11.00 M (Seq=  -10.57% : QoQ=  223.53%)
	  ST Debt         :         11.30 M (Seq=   13.00% : QoQ=   13.00%)
	  Other           :         16.90 M (Seq=   18.18% : QoQ=   52.25%)
	Working Capital   :        208.80 M (Ratio=6.33)
	WC + FCF          :         53.80 M

	Sharehldr Equity  :         72.60 M (Seq=  -34.06% : QoQ=  -67.39%)
	Tangible Assets   :        264.60 M (Seq=  -10.55% : QoQ=  -33.37%)
	LT Debt           :        146.90 M (Seq=   -1.08% : QoQ=   -1.80%)
	LT Debt to Equity :          2.02

	Last Price          :       11.13 : (52wkHi= 27.84 %offHigh=60%)
	PE                  :      275.00
	Op Margin           :     -962.45%
	Net Margin          :   -1,019.89%
	ROE                 :     -755.79%
	Interest % of sales :       82.53%
	Q0 Est Growth       :       16.02%
	Y1 Est Growth       :       34.31%

	FLXN State -->
	  Interest payments to sales is high at 82.53%.

	Zombie Score : 115.07
		Negative Sales        :    0.00
		Margins               :   35.00
		Available Cash to MC  :    0.00
		Interest Paid         :   35.00
		LT Debt to Equity     :    5.06
		Equity to MC          :    0.00
		OpsInc Growth 3Yr     :   35.00 : (-51.20%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    5.01

Rank : 6
 MDCO
	The Medicines Company : PARSIPPANY, NJ
	Healthcare, Pharmaceuticals, SP600
	Employees     :           62
	OpInc per Emp : $-15,738,709
	10Q Date      :  31-Mar-2019

	Market Cap        :      2,788.00 M
	Shares            :         74.46 M (Seq=    1.18% : QoQ=    0.90%)

	Sales 12m         :        488.60 M (Seq=  -86.38% : QoQ=  -99.08%)
	Ops Income 12m    :       -975.80 M (Seq=   71.22% : QoQ= -1,833.33%)
	Net Income 12m    :     -1,162.90 M (Seq=  -72.24% : QoQ=   39.85%)
	Interest Paid 12m :        195.90 M (Seq=    8.10% : QoQ=   43.94%)

	Cash <- Ops 12m   :       -202.20 M (Seq=  -27.69% : QoQ=   54.44%)
	  CapEx 12m       :          0.00 M (Seq=    0.00% : QoQ= -100.00%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :       -202.20 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :        174.00 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :        -28.20 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :         13.20 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :        -15.00 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        258.10 M (Seq=  -12.45% : QoQ=   -8.83%)
	  Cash            :        199.70 M (Seq=  -16.20% : QoQ=   -7.55%)
	  Acct Rx         :          0.00 M (Seq=    0.00% : QoQ= -100.00%)
	  ST Invest       :          2.40 M (Seq=   -7.69% : QoQ=  -90.20%)
	  Inventory       :          1.10 M (Seq=   22.22% : QoQ=  -77.08%)
	  Other           :         54.90 M (Seq=    3.58% : QoQ=   82.39%)
	Current Liabs     :         63.10 M (Seq=    8.05% : QoQ=  -42.90%)
	  Acct Pay        :         11.80 M (Seq= 1,585.71% : QoQ=  100.00%)
	  ST Debt         :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :         51.40 M (Seq=  -10.92% : QoQ=  -50.81%)
	Working Capital   :        195.00 M (Ratio=4.09)
	WC + FCF          :         -7.20 M

	Sharehldr Equity  :        -75.40 M (Seq= -238.12% : QoQ= -211.37%)
	Tangible Assets   :        635.30 M (Seq=   -0.90% : QoQ=   -3.83%)
	LT Debt           :        808.70 M (Seq=    2.01% : QoQ=   23.30%)
	LT Debt Tan Asset :          1.27

	Last Price          :       37.81 : (52wkHi= 41.57 %offHigh=9%)
	PE                  :      275.00
	Op Margin           :     -199.71%
	Net Margin          :     -238.01%
	ROE                 :        0.00%
	Interest % of sales :       40.09%
	Q0 Est Growth       :      110.61%
	Y1 Est Growth       :       15.30%

	MDCO State -->
	  Free Cash Flow plus Working Capital is negative (-7.20)
	  Running company with Financing. Cash from Financing greater than FCF plus Working Capital.
	  Interest payments to sales is high at 40.09%.
	  Shareholders have no equity.

	Zombie Score : 114.96
		Negative Sales        :   35.00
		Margins               :   35.00
		Available Cash to MC  :    0.26
		Interest Paid         :   35.00
		LT Debt to Equity     :    5.00
		Equity to MC          :    2.70
		OpsInc Growth 3Yr     :    2.00 : (-2.00%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00

Rank : 7
 INSM
	Insmed Incorporated : BRIDGEWATER, NJ
	Healthcare, Biotechnology & Medical Research
	Employees     :          373
	OpInc per Emp : $ -2,643,163
	10Q Date      :  31-Mar-2019

	Market Cap        :      1,776.03 M
	Shares            :         77.54 M (Seq=    0.57% : QoQ=    1.20%)

	Sales 12m         :         41.50 M (Seq=  223.47% : QoQ=    0.00%)
	Ops Income 12m    :       -985.90 M (Seq=   -1.49% : QoQ= -167.32%)
	Net Income 12m    :     -1,023.10 M (Seq=   -1.73% : QoQ= -179.10%)
	Interest Paid 12m :         61.50 M (Seq=    4.31% : QoQ=  817.24%)

	Cash <- Ops 12m   :       -264.30 M (Seq=   -6.19% : QoQ=   -9.50%)
	  CapEx 12m       :         11.70 M (Seq=   33.33% : QoQ=  -25.93%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :       -276.00 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :         10.90 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :       -253.40 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :        -13.50 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :       -266.90 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        454.60 M (Seq=  -12.39% : QoQ=  -34.72%)
	  Cash            :        420.20 M (Seq=  -15.13% : QoQ=  -38.80%)
	  Acct Rx         :          9.30 M (Seq=   69.09% : QoQ=    0.00%)
	  ST Invest       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Inventory       :         12.70 M (Seq=   81.43% : QoQ=    0.00%)
	  Other           :         12.40 M (Seq=    9.73% : QoQ=   26.53%)
	Current Liabs     :         94.30 M (Seq=   18.32% : QoQ=  170.98%)
	  Acct Pay        :         30.20 M (Seq=   70.62% : QoQ=  128.79%)
	  ST Debt         :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :         64.00 M (Seq=    3.23% : QoQ=  196.30%)
	Working Capital   :        360.30 M (Ratio=4.82)
	WC + FCF          :         84.30 M

	Sharehldr Equity  :        144.10 M (Seq=  -30.82% : QoQ=  -66.87%)
	Tangible Assets   :        538.50 M (Seq=   -1.36% : QoQ=  -24.69%)
	LT Debt           :        321.30 M (Seq=    1.48% : QoQ=    6.14%)
	LT Debt to Equity :          2.23

	Last Price          :       23.03 : (52wkHi= 33.13 %offHigh=30%)
	PE                  :      275.00
	Op Margin           :   -2,375.66%
	Net Margin          :   -2,465.30%
	ROE                 :     -709.99%
	Interest % of sales :      148.19%
	Q0 Est Growth       :        8.39%
	Y1 Est Growth       :       44.68%

	INSM State -->
	  Interest payments to sales is high at 148.19%.

	Zombie Score : 110.57
		Negative Sales        :    0.00
		Margins               :   35.00
		Available Cash to MC  :    0.00
		Interest Paid         :   35.00
		LT Debt to Equity     :    5.57
		Equity to MC          :    0.00
		OpsInc Growth 3Yr     :   35.00 : (-38.10%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00

Rank : 8
 IMMU
	Immunomedics, Inc. : MORRIS PLAINS, NJ
	Healthcare, Biotechnology & Medical Research
	Employees     :          346
	OpInc per Emp : $   -844,508
	10Q Date      :  31-Mar-2019

	Market Cap        :      3,938.95 M
	Shares            :        191.05 M (Seq=  -66.32% : QoQ=   15.05%)

	Sales 12m         :          5.70 M (Seq=    0.00% : QoQ=  -87.50%)
	Ops Income 12m    :       -292.20 M (Seq=  100.00% : QoQ=  100.00%)
	Net Income 12m    :       -946.70 M (Seq= -129.55% : QoQ= -513.56%)
	Interest Paid 12m :         88.20 M (Seq=   97.00% : QoQ=  616.36%)

	Cash <- Ops 12m   :       -223.40 M (Seq=   32.47% : QoQ=  -69.88%)
	  CapEx 12m       :         18.30 M (Seq=  -73.75% : QoQ=  -27.59%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :       -241.70 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :        326.60 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :        103.20 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :         28.70 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :        131.90 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        448.90 M (Seq=  -11.02% : QoQ=   21.59%)
	  Cash            :        437.90 M (Seq=  -11.16% : QoQ=   42.78%)
	  Acct Rx         :          0.00 M (Seq=    0.00% : QoQ= -100.00%)
	  ST Invest       :          4.70 M (Seq=   -4.08% : QoQ=  -90.96%)
	  Inventory       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :          6.20 M (Seq=   -7.46% : QoQ=  -39.22%)
	Current Liabs     :         56.90 M (Seq=   79.50% : QoQ=  -39.21%)
	  Acct Pay        :         53.90 M (Seq=   70.03% : QoQ=  132.33%)
	  ST Debt         :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :          3.00 M (Seq=    0.00% : QoQ=  -95.74%)
	Working Capital   :        392.00 M (Ratio=7.89)
	WC + FCF          :        150.30 M

	Sharehldr Equity  :        182.80 M (Seq=  -31.48% : QoQ=  151.79%)
	Tangible Assets   :        484.60 M (Seq=   -8.22% : QoQ=   27.56%)
	LT Debt           :          7.10 M (Seq=    0.00% : QoQ=  -96.48%)
	LT Debt to Equity :          0.04

	Last Price          :       14.02 : (52wkHi= 27.33 %offHigh=48%)
	PE                  :      275.00
	Op Margin           :   -5,126.32%
	Net Margin          :  -16,608.77%
	ROE                 :     -517.89%
	Interest % of sales :    1,547.37%
	Q0 Est Growth       :     -180.84%
	Y1 Est Growth       :     -300.00%

	IMMU State -->
	  Interest payments to sales is high at 1547.37%.

	Zombie Score : 110.36
		Negative Sales        :   35.00
		Margins               :   35.00
		Available Cash to MC  :    0.00
		Interest Paid         :   35.00
		LT Debt to Equity     :    0.00
		Equity to MC          :   -4.64
		OpsInc Growth 3Yr     :    0.00 : (0.00%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00
		Earnings weakness     :   10.00

Rank : 9
 AXDX
	Accelerate Diagnostics Inc : TUCSON, AZ
	Healthcare, Advanced Medical Equipment & Technology
	Employees     :          287
	OpInc per Emp : $ -1,008,362
	10Q Date      :  31-Mar-2019

	Market Cap        :      1,065.56 M
	Shares            :         54.34 M (Seq=    0.25% : QoQ=   -2.34%)
	Share Change 12m  :         -1.30 M (Buyback Est= $22.79M)

	Sales 12m         :         16.70 M (Seq=   15.79% : QoQ= 6,500.00%)
	Ops Income 12m    :       -289.40 M (Seq=    2.61% : QoQ=  -72.09%)
	Net Income 12m    :       -307.90 M (Seq=   -1.02% : QoQ=  -96.04%)
	Interest Paid 12m :         23.50 M (Seq=   32.67% : QoQ=    0.00%)

	Cash <- Ops 12m   :        -71.10 M (Seq=  -36.36% : QoQ=  -21.12%)
	  CapEx 12m       :          1.00 M (Seq=  100.00% : QoQ=  -77.78%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :        -72.10 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :         27.70 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :        -43.40 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :         -7.90 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :        -51.30 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        164.00 M (Seq=   -7.66% : QoQ=  -20.81%)
	  Cash            :         75.30 M (Seq=   13.57% : QoQ=  -40.62%)
	  Acct Rx         :          2.00 M (Seq=    5.26% : QoQ=   81.82%)
	  ST Invest       :         75.60 M (Seq=  -24.55% : QoQ=   13.17%)
	  Inventory       :          8.60 M (Seq=   11.69% : QoQ=  -14.85%)
	  Other           :          2.60 M (Seq=   62.50% : QoQ=   13.04%)
	Current Liabs     :          6.50 M (Seq=  -16.67% : QoQ=  -13.33%)
	  Acct Pay        :          2.50 M (Seq=   92.31% : QoQ=  -10.71%)
	  ST Debt         :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :          4.00 M (Seq=  -37.50% : QoQ=  -14.89%)
	Working Capital   :        157.50 M (Ratio=25.23)
	WC + FCF          :         85.40 M

	Sharehldr Equity  :         43.00 M (Seq=  -25.09% : QoQ=  -59.62%)
	Tangible Assets   :        172.10 M (Seq=   -7.07% : QoQ=  -19.20%)
	LT Debt           :        122.50 M (Seq=    2.00% : QoQ=   23.49%)
	LT Debt to Equity :          2.85

	Last Price          :       19.67 : (52wkHi= 24.75 %offHigh=20%)
	PE                  :      275.00
	Op Margin           :   -1,732.93%
	Net Margin          :   -1,843.71%
	ROE                 :     -716.05%
	Interest % of sales :      140.72%
	Q0 Est Growth       :       -9.63%
	Y1 Est Growth       :       14.25%

	AXDX State -->
	  Interest payments to sales is high at 140.72%.

	Zombie Score : 108.78
		Negative Sales        :    0.00
		Margins               :   35.00
		Available Cash to MC  :    0.00
		Interest Paid         :   35.00
		LT Debt to Equity     :    7.12
		Equity to MC          :    0.00
		OpsInc Growth 3Yr     :   20.80 : (-20.80%)
		Share Decline         :    5.85
		Price                 :    0.00
		Price % of 52wk High  :    0.00
		Earnings weakness     :    5.00

Rank : 10
 FOLD
	Amicus Therapeutics, Inc. : CRANBURY, NJ
	Healthcare, Biotechnology & Medical Research
	Employees     :          508
	OpInc per Emp : $ -2,669,488
	10Q Date      :  31-Mar-2019

	Market Cap        :      2,410.24 M
	Shares            :        213.52 M (Seq=   12.77% : QoQ=   21.33%)

	Sales 12m         :        241.70 M (Seq=   19.08% : QoQ=    0.00%)
	Ops Income 12m    :     -1,356.10 M (Seq=  -18.64% : QoQ= -196.88%)
	Net Income 12m    :     -1,252.40 M (Seq=  -20.17% : QoQ= -217.49%)
	Interest Paid 12m :         69.40 M (Seq=    8.93% : QoQ= 1,425.00%)

	Cash <- Ops 12m   :       -329.00 M (Seq=  -29.32% : QoQ=  -58.59%)
	  CapEx 12m       :          8.40 M (Seq=   70.59% : QoQ=  262.50%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :       -337.40 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :        171.60 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :       -157.40 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :        141.50 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :        -15.90 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        483.00 M (Seq=  -12.36% : QoQ=  -18.41%)
	  Cash            :         96.30 M (Seq=   20.83% : QoQ=  -15.75%)
	  Acct Rx         :         23.00 M (Seq=    4.55% : QoQ=  112.96%)
	  ST Invest       :        342.00 M (Seq=  -19.42% : QoQ=  -23.69%)
	  Inventory       :          8.20 M (Seq=   -2.38% : QoQ=    1.23%)
	  Other           :         13.60 M (Seq=  -18.07% : QoQ=   28.30%)
	Current Liabs     :         65.90 M (Seq=  -23.46% : QoQ=  -53.16%)
	  Acct Pay        :         60.60 M (Seq=  -24.81% : QoQ=   38.67%)
	  ST Debt         :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :          5.30 M (Seq=   -3.64% : QoQ=  -94.54%)
	Working Capital   :        417.10 M (Ratio=7.33)
	WC + FCF          :         79.70 M

	Sharehldr Equity  :        451.70 M (Seq=   31.73% : QoQ=  -13.40%)
	Tangible Assets   :        543.90 M (Seq=   -4.44% : QoQ=  -16.22%)
	LT Debt           :        168.80 M (Seq=  -47.53% : QoQ=    1.20%)
	LT Debt to Equity :          0.37

	Last Price          :       12.35 : (52wkHi= 16.82 %offHigh=26%)
	PE                  :      275.00
	Op Margin           :     -561.07%
	Net Margin          :     -518.16%
	ROE                 :     -277.26%
	Interest % of sales :       28.71%
	Q0 Est Growth       :      -44.37%
	Y1 Est Growth       :       74.72%

	FOLD State -->
	  Interest payments to sales is high at 28.71%.

	Zombie Score : 103.71
		Negative Sales        :    0.00
		Margins               :   35.00
		Available Cash to MC  :    0.00
		Interest Paid         :   28.71
		LT Debt to Equity     :    0.00
		Equity to MC          :    0.00
		OpsInc Growth 3Yr     :   35.00 : (-35.80%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00
		Earnings weakness     :    5.00

Rank : 11
 FATE
	Fate Therapeutics Inc : SAN DIEGO, CA
	Healthcare, Biotechnology & Medical Research
	Employees     :          104
	OpInc per Emp : $ -2,065,384
	10Q Date      :  31-Mar-2019

	Market Cap        :      1,214.24 M
	Shares            :         64.92 M (Seq=    0.36% : QoQ=   23.04%)

	Sales 12m         :         19.50 M (Seq=   34.04% : QoQ=  162.50%)
	Ops Income 12m    :       -214.80 M (Seq=   -9.54% : QoQ= -164.39%)
	Net Income 12m    :       -215.30 M (Seq=   -8.41% : QoQ= -140.67%)
	Interest Paid 12m :          6.30 M (Seq=    0.00% : QoQ=  -22.73%)

	Cash <- Ops 12m   :        -43.60 M (Seq=  -59.09% : QoQ=  -38.89%)
	  CapEx 12m       :          3.80 M (Seq=   54.55% : QoQ=  750.00%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :        -47.40 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :        141.80 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :         98.20 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :         52.20 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :        150.40 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        186.40 M (Seq=   -9.16% : QoQ=  105.74%)
	  Cash            :        183.00 M (Seq=   -3.94% : QoQ=  456.23%)
	  Acct Rx         :          0.50 M (Seq=    0.00% : QoQ=    0.00%)
	  ST Invest       :         10.50 M (Seq=  -62.37% : QoQ=  -12.50%)
	  Inventory       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :          2.90 M (Seq=  -21.62% : QoQ=   93.33%)
	Current Liabs     :         29.10 M (Seq=    6.59% : QoQ=  130.95%)
	  Acct Pay        :          5.40 M (Seq=   28.57% : QoQ=  145.45%)
	  ST Debt         :          3.90 M (Seq=   62.50% : QoQ=  387.50%)
	  Other           :         19.80 M (Seq=   -3.88% : QoQ=  104.12%)
	Working Capital   :        157.30 M (Ratio=6.41)
	WC + FCF          :        109.90 M

	Sharehldr Equity  :        145.80 M (Seq=   -9.16% : QoQ=  124.31%)
	Tangible Assets   :        220.90 M (Seq=    3.71% : QoQ=  136.51%)
	LT Debt           :         11.00 M (Seq=  -11.29% : QoQ=  -21.99%)
	LT Debt to Equity :          0.08

	Last Price          :       20.50 : (52wkHi= 22.35 %offHigh=8%)
	PE                  :      275.00
	Op Margin           :   -1,101.54%
	Net Margin          :   -1,104.10%
	ROE                 :     -147.67%
	Interest % of sales :       32.31%
	Q0 Est Growth       :      -60.45%
	Y1 Est Growth       :      -31.39%

	FATE State -->
	  Interest payments to sales is high at 32.31%.

	Zombie Score : 101.51
		Negative Sales        :    0.00
		Margins               :   35.00
		Available Cash to MC  :    0.00
		Interest Paid         :   32.31
		LT Debt to Equity     :    0.00
		Equity to MC          :  -10.00
		OpsInc Growth 3Yr     :   34.20 : (-34.20%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00
		Earnings weakness     :   10.00

Rank : 12
 CDZI
	Cadiz Inc : LOS ANGELES, CA
	Utilities, Utilities - Water & Related
	Employees     :            9
	OpInc per Emp : $ -5,633,333
	10Q Date      :  31-Mar-2019

	Market Cap        :        314.32 M
	Shares            :         25.33 M (Seq=    3.10% : QoQ=    9.76%)

	Sales 12m         :          1.60 M (Seq=    0.00% : QoQ=   33.33%)
	Ops Income 12m    :        -50.70 M (Seq=   -6.25% : QoQ=   15.00%)
	Net Income 12m    :       -114.10 M (Seq=   -4.94% : QoQ=  -15.00%)
	Interest Paid 12m :         63.90 M (Seq=    1.19% : QoQ=   68.32%)

	Cash <- Ops 12m   :        -12.20 M (Seq=  -14.29% : QoQ=   -2.56%)
	  CapEx 12m       :          1.40 M (Seq=  -60.00% : QoQ=  -60.00%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :        -13.60 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :         23.40 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :         11.20 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :         -3.40 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :          7.80 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :         16.90 M (Seq=   30.00% : QoQ=   81.72%)
	  Cash            :         16.20 M (Seq=   28.57% : QoQ=   88.37%)
	  Acct Rx         :          0.10 M (Seq=    0.00% : QoQ=    0.00%)
	  ST Invest       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Inventory       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :          0.70 M (Seq=   75.00% : QoQ=    0.00%)
	Current Liabs     :          3.10 M (Seq=  -24.39% : QoQ=  -18.42%)
	  Acct Pay        :          1.00 M (Seq=  400.00% : QoQ=  -16.67%)
	  ST Debt         :          0.10 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :          2.00 M (Seq=  -48.72% : QoQ=  -20.00%)
	Working Capital   :         13.80 M (Ratio=5.45)
	WC + FCF          :          0.20 M

	Sharehldr Equity  :        -81.40 M (Seq=    5.57% : QoQ=    1.81%)
	Tangible Assets   :         70.10 M (Seq=    7.02% : QoQ=   18.61%)
	LT Debt           :        151.40 M (Seq=    0.46% : QoQ=    7.91%)
	LT Debt Tan Asset :          2.16

	Last Price          :       12.80 : (52wkHi= 13.55 %offHigh=5%)
	PE                  :      275.00
	Op Margin           :   -3,168.75%
	Net Margin          :   -7,131.25%
	ROE                 :        0.00%
	Interest % of sales :    3,993.75%
	Q0 Est Growth       :        0.00%
	Y1 Est Growth       :        0.00%

	CDZI State -->
	  Interest payments to sales is high at 3993.75%.
	  Shareholders have no equity.

	Zombie Score : 100.90
		Negative Sales        :    0.00
		Margins               :   35.00
		Available Cash to MC  :    0.00
		Interest Paid         :   35.00
		LT Debt to Equity     :    5.00
		Equity to MC          :   25.90
		OpsInc Growth 3Yr     :    0.00 : (7.10%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00

Rank : 13
 LXRX
	Lexicon Pharmaceuticals, Inc. : THE WOODLANDS, TX
	Healthcare, Biotechnology & Medical Research
	Employees     :          202
	OpInc per Emp : $ -2,197,029
	10Q Date      :  31-Mar-2019

	Market Cap        :        671.57 M
	Shares            :        106.05 M (Seq=    0.13% : QoQ=    0.37%)

	Sales 12m         :        281.40 M (Seq=  -25.32% : QoQ=  -63.69%)
	Ops Income 12m    :       -443.80 M (Seq=   19.94% : QoQ= -5,613.33%)
	Net Income 12m    :       -475.20 M (Seq=   16.76% : QoQ= -2,034.04%)
	Interest Paid 12m :         55.20 M (Seq=    0.00% : QoQ=  210.45%)

	Cash <- Ops 12m   :       -127.40 M (Seq=    5.54% : QoQ=   45.30%)
	  CapEx 12m       :          0.10 M (Seq=    0.00% : QoQ=    0.00%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :       -127.50 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :         -2.00 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :       -129.40 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :        154.90 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :         25.50 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        146.80 M (Seq=  -15.29% : QoQ=  -46.27%)
	  Cash            :         45.80 M (Seq=  -43.03% : QoQ=  124.51%)
	  Acct Rx         :          4.40 M (Seq=  -25.42% : QoQ=   -2.22%)
	  ST Invest       :         87.40 M (Seq=    9.66% : QoQ=  -63.87%)
	  Inventory       :          4.60 M (Seq=   -2.13% : QoQ=  119.05%)
	  Other           :          4.70 M (Seq=   74.07% : QoQ=    9.30%)
	Current Liabs     :         28.20 M (Seq=  -23.37% : QoQ=  -71.91%)
	  Acct Pay        :         13.90 M (Seq=  -21.91% : QoQ=  -79.13%)
	  ST Debt         :          1.10 M (Seq=    0.00% : QoQ=  -91.85%)
	  Other           :         13.20 M (Seq=  -26.26% : QoQ=  -34.98%)
	Working Capital   :        118.60 M (Ratio=5.21)
	WC + FCF          :         -8.90 M

	Sharehldr Equity  :        -45.70 M (Seq=  -73.11% : QoQ= -274.43%)
	Tangible Assets   :        164.30 M (Seq=  -13.25% : QoQ=  -43.50%)
	LT Debt           :         24.60 M (Seq=  -89.91% : QoQ=  -89.39%)
	LT Debt Tan Asset :          0.15

	Last Price          :        6.34 : (52wkHi= 13.31 %offHigh=52%)
	PE                  :      275.00
	Op Margin           :     -157.71%
	Net Margin          :     -168.87%
	ROE                 :        0.00%
	Interest % of sales :       19.62%
	Q0 Est Growth       :      241.67%
	Y1 Est Growth       :      232.05%

	LXRX State -->
	  Free Cash Flow plus Working Capital is negative (-8.90)
	  Interest payments to sales is high at 19.62%.
	  Shareholders have no equity.

	Zombie Score : 100.39
		Negative Sales        :   35.00
		Margins               :   32.66
		Available Cash to MC  :    1.31
		Interest Paid         :   19.62
		LT Debt to Equity     :    5.00
		Equity to MC          :    6.80
		OpsInc Growth 3Yr     :   35.00 : (-316.70%)
		Share Decline         :    0.00
		Price                 :  -35.00
		Price % of 52wk High  :    0.00

Rank : 14
 TMDX
	TransMedics Group Inc : ANDOVER, MA
	Healthcare, Advanced Medical Equipment & Technology
	Employees     :           92
	OpInc per Emp : $   -924,999
	10Q Date      :  30-Mar-2019

	Market Cap        :        129.11 M
	Shares            :         20.20 M (Seq=    0.00% : QoQ=    0.00%)

	Sales 12m         :         42.10 M (Seq=   16.92% : QoQ=    0.00%)
	Ops Income 12m    :        -85.10 M (Seq=   -6.44% : QoQ=    0.00%)
	Net Income 12m    :        -94.40 M (Seq=   -7.98% : QoQ=    0.00%)
	Interest Paid 12m :          8.40 M (Seq=   33.33% : QoQ=    0.00%)

	Cash <- Ops 12m   :        -13.40 M (Seq=  -19.67% : QoQ=  -15.87%)
	  CapEx 12m       :          0.10 M (Seq=    0.00% : QoQ=    0.00%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :        -13.50 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :         -3.00 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :        -16.40 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :          4.90 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :        -11.50 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :         30.10 M (Seq=  -13.51% : QoQ=    0.00%)
	  Cash            :         12.20 M (Seq=  -39.60% : QoQ=    0.00%)
	  Acct Rx         :          5.10 M (Seq=   50.00% : QoQ=    0.00%)
	  ST Invest       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Inventory       :         11.30 M (Seq=   21.51% : QoQ=    0.00%)
	  Other           :          1.40 M (Seq=  -22.22% : QoQ=    0.00%)
	Current Liabs     :         16.20 M (Seq=   28.57% : QoQ=    0.00%)
	  Acct Pay        :          5.50 M (Seq=   17.02% : QoQ=    0.00%)
	  ST Debt         :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :         10.70 M (Seq=   37.18% : QoQ=    0.00%)
	Working Capital   :         13.90 M (Ratio=1.86)
	WC + FCF          :          0.40 M

	Sharehldr Equity  :       -199.00 M (Seq=   -3.54% : QoQ=    0.00%)
	Tangible Assets   :         38.80 M (Seq=   -8.06% : QoQ=    0.00%)
	LT Debt           :         33.80 M (Seq=    0.30% : QoQ=    0.00%)
	LT Debt Tan Asset :          0.87

	Last Price          :       25.56 : (52wkHi= 31.54 %offHigh=18%)
	PE                  :      275.00
	Op Margin           :     -202.14%
	Net Margin          :     -224.23%
	ROE                 :        0.00%
	Interest % of sales :       19.95%
	Q0 Est Growth       :     -199.59%
	Y1 Est Growth       :     -132.37%

	TMDX State -->
	  Interest payments to sales is high at 19.95%.
	  Shareholders have no equity.

	Zombie Score : 99.95
		Negative Sales        :    0.00
		Margins               :   35.00
		Available Cash to MC  :    0.00
		Interest Paid         :   19.95
		LT Debt to Equity     :    5.00
		Equity to MC          :   30.00
		OpsInc Growth 3Yr     :    0.00 : (0.00%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00
		Earnings weakness     :   10.00

Rank : 15
 RVNC
	Revance Therapeutics Inc : NEWARK, CA
	Healthcare, Biotechnology & Medical Research
	Employees     :          170
	OpInc per Emp : $ -2,491,176
	10Q Date      :  31-Mar-2019

	Market Cap        :        464.37 M
	Shares            :         41.60 M (Seq=   14.48% : QoQ=   15.71%)

	Sales 12m         :          8.10 M (Seq=    2.70% : QoQ= 1,166.67%)
	Ops Income 12m    :       -423.50 M (Seq=  -18.44% : QoQ= -173.70%)
	Net Income 12m    :       -426.00 M (Seq=  -18.24% : QoQ= -126.71%)
	Interest Paid 12m :          2.80 M (Seq= -100.00% : QoQ= -100.00%)

	Cash <- Ops 12m   :       -115.60 M (Seq=   63.34% : QoQ=   -2.70%)
	  CapEx 12m       :          8.00 M (Seq=  -31.25% : QoQ=    0.00%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :       -123.60 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :        108.70 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :         -6.90 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :       -210.40 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :       -217.30 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        277.10 M (Seq=   33.29% : QoQ=    1.35%)
	  Cash            :         65.30 M (Seq=  -10.91% : QoQ=   -5.64%)
	  Acct Rx         :         27.00 M (Seq=    0.00% : QoQ=    0.00%)
	  ST Invest       :        205.70 M (Seq=  100.49% : QoQ=    3.06%)
	  Inventory       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :          6.10 M (Seq=   19.61% : QoQ=   32.61%)
	Current Liabs     :         34.10 M (Seq=    6.56% : QoQ=   48.26%)
	  Acct Pay        :          4.50 M (Seq=  -46.43% : QoQ=  -16.67%)
	  ST Debt         :          0.00 M (Seq=    0.00% : QoQ= -100.00%)
	  Other           :         29.60 M (Seq=   25.96% : QoQ=   77.25%)
	Working Capital   :        243.00 M (Ratio=8.13)
	WC + FCF          :        119.40 M

	Sharehldr Equity  :        221.10 M (Seq=   51.85% : QoQ=   -6.55%)
	Tangible Assets   :        324.50 M (Seq=   43.39% : QoQ=   13.94%)
	LT Debt           :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	LT Debt to Equity :          0.00

	Last Price          :       12.35 : (52wkHi= 30.60 %offHigh=59%)
	PE                  :      275.00
	Op Margin           :   -5,228.40%
	Net Margin          :   -5,259.26%
	ROE                 :     -192.67%
	Interest % of sales :       34.57%
	Q0 Est Growth       :       19.08%
	Y1 Est Growth       :       14.31%

	RVNC State -->
	  Interest payments to sales is high at 34.57%.

	Zombie Score : 99.79
		Negative Sales        :    0.00
		Margins               :   35.00
		Available Cash to MC  :    0.00
		Interest Paid         :   34.57
		LT Debt to Equity     :    0.00
		Equity to MC          :    0.00
		OpsInc Growth 3Yr     :   25.40 : (-25.40%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    4.82

Rank : 16
 CYTK
	Cytokinetics, Inc. : SOUTH SAN FRANCISCO, CA
	Healthcare, Biotechnology & Medical Research, SP600
	Employees     :          130
	OpInc per Emp : $ -2,083,846
	10Q Date      :  31-Mar-2019

	Market Cap        :        614.89 M
	Shares            :         54.82 M (Seq=    0.23% : QoQ=    1.40%)

	Sales 12m         :        186.00 M (Seq=   10.16% : QoQ=   20.91%)
	Ops Income 12m    :       -270.90 M (Seq=    1.80% : QoQ= -133.42%)
	Net Income 12m    :       -323.00 M (Seq=    0.85% : QoQ= -181.07%)
	Interest Paid 12m :         13.60 M (Seq=    7.89% : QoQ= 1,266.67%)

	Cash <- Ops 12m   :        -98.20 M (Seq= -118.70% : QoQ=    9.73%)
	  CapEx 12m       :          1.00 M (Seq=   50.00% : QoQ=    0.00%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :        -99.20 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :         18.10 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :        -80.10 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :          4.60 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :        -75.50 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        186.40 M (Seq=  -10.26% : QoQ=  -31.55%)
	  Cash            :         39.40 M (Seq=   -6.86% : QoQ=  -65.74%)
	  Acct Rx         :          6.60 M (Seq=   -2.94% : QoQ=  -64.52%)
	  ST Invest       :        137.20 M (Seq=  -12.33% : QoQ=    0.59%)
	  Inventory       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :          3.10 M (Seq=   40.91% : QoQ=   34.78%)
	Current Liabs     :         26.30 M (Seq=   18.47% : QoQ=  -31.69%)
	  Acct Pay        :          2.50 M (Seq=  -34.21% : QoQ=    4.17%)
	  ST Debt         :          6.20 M (Seq=  138.46% : QoQ=    0.00%)
	  Other           :         17.50 M (Seq=   10.76% : QoQ=  -51.52%)
	Working Capital   :        160.10 M (Ratio=7.09)
	WC + FCF          :         60.90 M

	Sharehldr Equity  :          3.40 M (Seq=  -86.87% : QoQ=  -96.59%)
	Tangible Assets   :        198.60 M (Seq=   -5.97% : QoQ=  -29.05%)
	LT Debt           :         36.40 M (Seq=   -8.54% : QoQ=   13.75%)
	LT Debt to Equity :         10.71

	Last Price          :       11.26 : (52wkHi= 11.58 %offHigh=2%)
	PE                  :      275.00
	Op Margin           :     -145.65%
	Net Margin          :     -173.66%
	ROE                 :   -9,500.00%
	Interest % of sales :        7.31%
	Q0 Est Growth       :       34.29%
	Y1 Est Growth       :       11.21%

	CYTK State -->
	  LT debt to equity of 10.71 is high.

	Zombie Score : 99.51
		Negative Sales        :    0.00
		Margins               :   31.93
		Available Cash to MC  :    0.00
		Interest Paid         :    7.31
		LT Debt to Equity     :   26.76
		Equity to MC          :    0.00
		OpsInc Growth 3Yr     :   33.50 : (-33.50%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00

Rank : 17
 PTLA
	Portola Pharmaceuticals Inc : SOUTH SAN FRANCISCO, CA
	Healthcare, Biotechnology & Medical Research
	Employees     :          324
	OpInc per Emp : $ -3,769,135
	10Q Date      :  31-Mar-2019

	Market Cap        :      1,776.35 M
	Shares            :         67.07 M (Seq=    0.85% : QoQ=    2.38%)

	Sales 12m         :        153.80 M (Seq=   38.90% : QoQ=  360.33%)
	Ops Income 12m    :     -1,221.20 M (Seq=    3.39% : QoQ=  -46.83%)
	Net Income 12m    :     -1,249.50 M (Seq=    1.71% : QoQ=  -51.96%)
	Interest Paid 12m :         52.90 M (Seq=   20.86% : QoQ=    0.00%)

	Cash <- Ops 12m   :       -301.30 M (Seq=   -0.32% : QoQ=   28.05%)
	  CapEx 12m       :          2.40 M (Seq=  -70.00% : QoQ=  -40.00%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :       -303.70 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :        174.50 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :       -126.80 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :        186.60 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :         59.80 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        354.90 M (Seq=    0.45% : QoQ=  -18.64%)
	  Cash            :        226.80 M (Seq=   63.17% : QoQ=   34.68%)
	  Acct Rx         :         18.10 M (Seq=   15.29% : QoQ=  182.81%)
	  ST Invest       :         96.00 M (Seq=  -46.07% : QoQ=  -60.03%)
	  Inventory       :          2.70 M (Seq=  -65.82% : QoQ=  -15.62%)
	  Other           :         11.20 M (Seq=  -12.50% : QoQ=  -38.12%)
	Current Liabs     :         73.80 M (Seq=    6.96% : QoQ=   28.35%)
	  Acct Pay        :          9.70 M (Seq=  -26.52% : QoQ=  -53.37%)
	  ST Debt         :         15.10 M (Seq=   27.97% : QoQ=    0.00%)
	  Other           :         49.00 M (Seq=   11.36% : QoQ=   33.51%)
	Working Capital   :        281.10 M (Ratio=4.81)
	WC + FCF          :        -22.60 M

	Sharehldr Equity  :         48.40 M (Seq=  -45.25% : QoQ=  -84.29%)
	Tangible Assets   :        393.30 M (Seq=    3.75% : QoQ=  -19.57%)
	LT Debt           :        260.60 M (Seq=   28.00% : QoQ=  142.64%)
	LT Debt to Equity :          5.38

	Last Price          :       26.75 : (52wkHi= 42.17 %offHigh=36%)
	PE                  :      275.00
	Op Margin           :     -794.02%
	Net Margin          :     -812.42%
	ROE                 :   -2,581.61%
	Interest % of sales :       34.40%
	Q0 Est Growth       :       59.07%
	Y1 Est Growth       :       79.34%

	PTLA State -->
	  Free Cash Flow plus Working Capital is negative (-22.60)
	  Running company with Financing. Cash from Financing greater than FCF plus Working Capital.
	  Interest payments to sales is high at 34.40%.
	  LT debt to equity of 5.38 is high.

	Zombie Score : 98.99
		Negative Sales        :    0.00
		Margins               :   35.00
		Available Cash to MC  :    1.14
		Interest Paid         :   34.40
		LT Debt to Equity     :   13.46
		Equity to MC          :    0.00
		OpsInc Growth 3Yr     :   15.00 : (-15.00%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00

Rank : 18
 MDR
	McDermott International Inc : HOUSTON, TX
	Energy, Oil & Gas - Related Services And Equipment, SP400
	Employees     :       31,900
	OpInc per Emp : $   -129,090
	10Q Date      :  31-Mar-2019

	Market Cap        :      1,799.84 M
	Shares            :        181.00 M (Seq=    0.56% : QoQ=   37.12%)

	Sales 12m         :     20,634.00 M (Seq=   23.91% : QoQ=  170.59%)
	Ops Income 12m    :     -4,118.00 M (Seq=   -2.26% : QoQ= -2,147.03%)
	Net Income 12m    :     -5,274.00 M (Seq=   -3.90% : QoQ= -15,433.33%)
	Interest Paid 12m :        845.00 M (Seq=   31.27% : QoQ=  578.64%)

	Cash <- Ops 12m   :       -352.10 M (Seq=   14.39% : QoQ= -757.68%)
	  CapEx 12m       :         85.60 M (Seq=  -25.00% : QoQ=   -2.17%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :       -437.70 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :      3,484.70 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :      3,132.60 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :     -2,761.10 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :        371.50 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :      3,239.00 M (Seq=    6.79% : QoQ=  128.65%)
	  Cash            :        413.00 M (Seq=  -20.58% : QoQ=    0.07%)
	  Acct Rx         :      2,132.00 M (Seq=   17.73% : QoQ=  439.61%)
	  ST Invest       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Inventory       :        106.00 M (Seq=    4.95% : QoQ=    0.00%)
	  Other           :        588.00 M (Seq=   -2.16% : QoQ=   -3.42%)
	Current Liabs     :      4,618.00 M (Seq=    9.51% : QoQ=  623.48%)
	  Acct Pay        :        949.00 M (Seq=   59.50% : QoQ=  397.90%)
	  ST Debt         :        208.00 M (Seq=  447.37% : QoQ=  755.97%)
	  Other           :      3,461.00 M (Seq=   -3.43% : QoQ=  717.43%)
	Working Capital   :     -1,379.00 M (Ratio=0.70)
	WC + FCF          :     -1,816.70 M

	Sharehldr Equity  :        679.00 M (Seq=  -15.12% : QoQ=  -62.53%)
	Tangible Assets   :      6,369.00 M (Seq=   10.25% : QoQ=   98.99%)
	LT Debt           :      3,393.00 M (Seq=   -1.91% : QoQ=  561.40%)
	LT Debt to Equity :          5.00

	Last Price          :       10.51 : (52wkHi= 20.63 %offHigh=49%)
	PE                  :      275.00
	Op Margin           :      -19.96%
	Net Margin          :      -25.56%
	ROE                 :     -776.73%
	Interest % of sales :        4.10%
	Q0 Est Growth       :     -104.15%
	Y1 Est Growth       :      300.00%

	MDR State -->
	  Free Cash Flow plus Working Capital is negative (-1816.70)
	  Running company with Financing. Cash from Financing greater than FCF plus Working Capital.

	Zombie Score : 96.14
		Negative Sales        :    0.00
		Margins               :    4.55
		Available Cash to MC  :   35.00
		Interest Paid         :    4.10
		LT Debt to Equity     :   12.49
		Equity to MC          :    0.00
		OpsInc Growth 3Yr     :   35.00 : (-180.30%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00
		Earnings weakness     :    5.00

Rank : 19
 JACK
	Jack in the Box Inc. : SAN DIEGO, CA
	Consumer Cyclicals, Restaurants & Bars, SP400
	Employees     :        5,200
	OpInc per Emp : $    177,134
	10Q Date      :  14-Apr-2019

	Market Cap        :      2,128.80 M
	Shares            :         25.94 M (Seq=    0.14% : QoQ=  -10.66%)
	Share Change 12m  :         -3.10 M (Buyback Est= $260.43M)

	Sales 12m         :      4,438.30 M (Seq=    0.26% : QoQ=  -43.39%)
	Ops Income 12m    :        921.10 M (Seq=   -6.09% : QoQ=   10.29%)
	Net Income 12m    :        501.60 M (Seq=   -0.49% : QoQ=   11.03%)
	Interest Paid 12m :        170.40 M (Seq=   16.77% : QoQ=  182.81%)

	Cash <- Ops 12m   :        134.90 M (Seq=  -38.30% : QoQ=  166.29%)
	  CapEx 12m       :         18.20 M (Seq=  -37.50% : QoQ=   70.73%)
	  Dividends 12m   :        160.38 M (Yield=7.53%)
	    FCF 12m       :        -43.68 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :       -173.10 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :        -38.20 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :         38.60 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :          0.40 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        105.30 M (Seq=    9.12% : QoQ=  -27.43%)
	  Cash            :          1.60 M (Seq=  -62.79% : QoQ=   33.33%)
	  Acct Rx         :         70.80 M (Seq=   13.46% : QoQ=  -30.86%)
	  ST Invest       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Inventory       :          1.90 M (Seq=   -9.52% : QoQ=  -26.92%)
	  Other           :         31.00 M (Seq=   11.91% : QoQ=  -20.51%)
	Current Liabs     :        182.10 M (Seq=   -2.98% : QoQ=    8.72%)
	  Acct Pay        :         25.10 M (Seq=  -43.85% : QoQ=    2.45%)
	  ST Debt         :         42.60 M (Seq=    0.24% : QoQ=   -0.70%)
	  Other           :        114.40 M (Seq=   13.94% : QoQ=   14.17%)
	Working Capital   :        -76.80 M (Ratio=0.58)
	WC + FCF          :       -120.48 M

	Sharehldr Equity  :       -592.50 M (Seq=    2.44% : QoQ=  -37.50%)
	Tangible Assets   :        784.90 M (Seq=    0.42% : QoQ=   -5.08%)
	LT Debt           :      1,014.90 M (Seq=    0.12% : QoQ=   12.72%)
	LT Debt Tan Asset :          1.29

	Last Price          :       79.64 : (52wkHi= 93.98 %offHigh=15%)
	PE                  :        4.64
	Op Margin           :       20.75%
	Net Margin          :       11.30%
	ROE                 :        0.00%
	Interest % of sales :        3.84%
	EPS Yield           :       21.57% ($17.18)
	Q0 Est Growth       :       45.34%
	Y1 Est Growth       :      -33.17%

	JACK State -->
	  Free Cash Flow plus Working Capital is negative (-120.48) with dividend paid 160.38.
	  Shareholders have no equity.

	Zombie Score : 91.67
		Negative Sales        :   35.00
		Margins               :    0.00
		Available Cash to MC  :    0.00
		Interest Paid         :    3.84
		LT Debt to Equity     :    5.00
		Equity to MC          :   27.83
		OpsInc Growth 3Yr     :    0.00 : (5.50%)
		Share Decline         :   15.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00
		Earnings weakness     :    5.00

Rank : 20
 MLNT
	Melinta Therapeutics Inc : MORRISTOWN, NJ
	Healthcare, Biotechnology & Medical Research
	Employees     :          290
	OpInc per Emp : $ -1,678,620
	10Q Date      :  31-Mar-2019

	Market Cap        :         53.53 M
	Shares            :         11.33 M (Seq=    0.93% : QoQ=   83.21%)

	Sales 12m         :        244.00 M (Seq=   -0.73% : QoQ=  250.55%)
	Ops Income 12m    :       -486.80 M (Seq=   13.68% : QoQ=  -51.18%)
	Net Income 12m    :       -507.70 M (Seq=    1.84% : QoQ=  -69.37%)
	Interest Paid 12m :         92.70 M (Seq=   -5.79% : QoQ= 1,750.00%)

	Cash <- Ops 12m   :       -157.40 M (Seq= -4,562.50% : QoQ=   27.43%)
	  CapEx 12m       :          1.60 M (Seq=  -60.00% : QoQ=    0.00%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :       -159.00 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :        187.30 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :         29.90 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :         -4.30 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :         25.60 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        181.80 M (Seq=   21.61% : QoQ=   21.28%)
	  Cash            :        116.90 M (Seq=   42.91% : QoQ=   27.76%)
	  Acct Rx         :         14.90 M (Seq=  -33.78% : QoQ=  -34.93%)
	  ST Invest       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Inventory       :         44.50 M (Seq=    7.75% : QoQ=   57.80%)
	  Other           :          5.50 M (Seq=   44.74% : QoQ=  -24.66%)
	Current Liabs     :        130.00 M (Seq=   -2.69% : QoQ=   28.59%)
	  Acct Pay        :          8.30 M (Seq=  -50.60% : QoQ=  -33.60%)
	  ST Debt         :          5.60 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :        121.60 M (Seq=    9.35% : QoQ=   37.25%)
	Working Capital   :         51.80 M (Ratio=1.40)
	WC + FCF          :       -107.20 M

	Sharehldr Equity  :        176.50 M (Seq=   -7.15% : QoQ=  -11.66%)
	Tangible Assets   :        245.30 M (Seq=   15.49% : QoQ=   40.33%)
	LT Debt           :        153.70 M (Seq=   39.10% : QoQ=   44.86%)
	LT Debt to Equity :          0.87

	Last Price          :        5.12 : (52wkHi= 32.75 %offHigh=84%)
	PE                  :      275.00
	Op Margin           :     -199.51%
	Net Margin          :     -208.07%
	ROE                 :     -287.65%
	Interest % of sales :       37.99%
	Q0 Est Growth       :      125.29%
	Y1 Est Growth       :      124.96%

	MLNT State -->
	  Free Cash Flow plus Working Capital is negative (-107.20)
	  Running company with Financing. Cash from Financing greater than FCF plus Working Capital.
	  Interest payments to sales is high at 37.99%.

	Zombie Score : 90.50
		Negative Sales        :    0.00
		Margins               :   35.00
		Available Cash to MC  :   35.00
		Interest Paid         :   35.00
		LT Debt to Equity     :    0.00
		Equity to MC          :    0.00
		OpsInc Growth 3Yr     :   20.50 : (-20.50%)
		Share Decline         :    0.00
		Price                 :  -35.00
		Price % of 52wk High  :    0.00

Rank : 21
 CLVS
	Clovis Oncology Inc : BOULDER, CO
	Healthcare, Biotechnology & Medical Research
	Employees     :          468
	OpInc per Emp : $ -3,093,589
	10Q Date      :  31-Mar-2019

	Market Cap        :        727.86 M
	Shares            :         52.89 M (Seq=    0.30% : QoQ=    4.52%)

	Sales 12m         :        261.00 M (Seq=   15.30% : QoQ=    0.00%)
	Ops Income 12m    :     -1,447.80 M (Seq=   -2.32% : QoQ=    1.73%)
	Net Income 12m    :     -1,440.20 M (Seq=   -2.36% : QoQ=   -6.74%)
	Interest Paid 12m :         46.20 M (Seq=    6.82% : QoQ=   67.86%)

	Cash <- Ops 12m   :       -363.80 M (Seq=  -19.11% : QoQ=    2.09%)
	  CapEx 12m       :         10.30 M (Seq=  -20.00% : QoQ=  500.00%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :       -374.10 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :        389.10 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :         25.30 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :       -275.20 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :       -249.90 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        467.10 M (Seq=  -18.38% : QoQ=  -16.54%)
	  Cash            :        123.30 M (Seq=  -44.43% : QoQ=  -67.04%)
	  Acct Rx         :         24.20 M (Seq=   59.21% : QoQ=   64.63%)
	  ST Invest       :        283.50 M (Seq=   -4.96% : QoQ=  216.05%)
	  Inventory       :         25.00 M (Seq=   -7.75% : QoQ=  -63.87%)
	  Other           :         11.10 M (Seq=   12.12% : QoQ=   -7.50%)
	Current Liabs     :        106.40 M (Seq=  -15.35% : QoQ=   24.59%)
	  Acct Pay        :         43.30 M (Seq=   51.93% : QoQ=  223.13%)
	  ST Debt         :          1.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :         63.10 M (Seq=  -34.41% : QoQ=  -12.48%)
	Working Capital   :        360.70 M (Ratio=4.39)
	WC + FCF          :        -13.40 M

	Sharehldr Equity  :         74.90 M (Seq=  -48.87% : QoQ=  -75.54%)
	Tangible Assets   :        655.70 M (Seq=  -12.41% : QoQ=   10.61%)
	LT Debt           :        576.00 M (Seq=    0.09% : QoQ=  103.75%)
	LT Debt to Equity :          7.69

	Last Price          :       13.83 : (52wkHi= 49.90 %offHigh=72%)
	PE                  :      275.00
	Op Margin           :     -554.71%
	Net Margin          :     -551.80%
	ROE                 :   -1,922.83%
	Interest % of sales :       17.70%
	Q0 Est Growth       :      -34.98%
	Y1 Est Growth       :       10.70%

	CLVS State -->
	  Free Cash Flow plus Working Capital is negative (-13.40)
	  Running company with Financing. Cash from Financing greater than FCF plus Working Capital.
	  Interest payments to sales is high at 17.70%.
	  LT debt to equity of 7.69 is high.

	Zombie Score : 88.49
		Negative Sales        :    0.00
		Margins               :   35.00
		Available Cash to MC  :    0.43
		Interest Paid         :   17.70
		LT Debt to Equity     :   19.23
		Equity to MC          :    0.00
		OpsInc Growth 3Yr     :    0.00 : (1.30%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :   11.14
		Earnings weakness     :    5.00

Rank : 22
 PZZA
	Papa John's Int'l, Inc. : LOUISVILLE, KY
	Consumer Cyclicals, Restaurants & Bars, SP400
	Employees     :       18,000
	OpInc per Emp : $     19,744
	10Q Date      :  31-Mar-2019

	Market Cap        :      1,457.21 M
	Shares            :         31.55 M (Seq=   -0.55% : QoQ=   -5.18%)
	Share Change 12m  :         -1.73 M (Buyback Est= $85.06M)

	Sales 12m         :      6,614.70 M (Seq=   -1.84% : QoQ=   -5.68%)
	Ops Income 12m    :        355.40 M (Seq=  -71.71% : QoQ=  -93.06%)
	Net Income 12m    :        189.10 M (Seq= -1,275.00% : QoQ= -124.93%)
	Interest Paid 12m :         70.60 M (Seq=    5.14% : QoQ=  366.67%)

	Cash <- Ops 12m   :         45.60 M (Seq=  153.08% : QoQ=  -66.34%)
	  CapEx 12m       :         41.30 M (Seq=  -23.68% : QoQ=   -6.45%)
	  Dividends 12m   :        107.78 M (Yield=7.40%)
	    FCF 12m       :       -103.48 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :        -32.40 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :         13.20 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :        -42.70 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :        -29.50 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        199.40 M (Seq=    1.58% : QoQ=   11.21%)
	  Cash            :         29.30 M (Seq=  -12.01% : QoQ=   -8.15%)
	  Acct Rx         :         92.20 M (Seq=   -7.62% : QoQ=   36.39%)
	  ST Invest       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Inventory       :         26.10 M (Seq=   -4.04% : QoQ=   -7.77%)
	  Other           :         51.80 M (Seq=   43.49% : QoQ=    0.78%)
	Current Liabs     :        218.60 M (Seq=   17.84% : QoQ=   39.68%)
	  Acct Pay        :         35.20 M (Seq=   29.89% : QoQ=   13.18%)
	  ST Debt         :         30.00 M (Seq=   50.00% : QoQ=   50.00%)
	  Other           :        153.40 M (Seq=   10.84% : QoQ=   45.54%)
	Working Capital   :        -19.20 M (Ratio=0.91)
	WC + FCF          :       -122.68 M

	Sharehldr Equity  :       -328.70 M (Seq=   -2.98% : QoQ=  -23.80%)
	Tangible Assets   :        655.90 M (Seq=   28.26% : QoQ=   33.02%)
	LT Debt           :        351.80 M (Seq=  -42.00% : QoQ=  -38.90%)
	LT Debt Tan Asset :          0.54

	Last Price          :       45.97 : (52wkHi= 60.56 %offHigh=24%)
	PE                  :        9.53
	Op Margin           :        5.37%
	Net Margin          :        2.86%
	ROE                 :        0.00%
	Interest % of sales :        1.07%
	EPS Yield           :       10.49% ($4.82)
	Q0 Est Growth       :     -130.46%
	Y1 Est Growth       :      300.00%

	PZZA State -->
	  Free Cash Flow plus Working Capital is negative (-122.68) with dividend paid 107.78.
	  Shareholders have no equity.

	Zombie Score : 87.26
		Negative Sales        :    5.68
		Margins               :    0.00
		Available Cash to MC  :    0.00
		Interest Paid         :    1.07
		LT Debt to Equity     :    5.00
		Equity to MC          :   22.56
		OpsInc Growth 3Yr     :   35.00 : (-37.40%)
		Share Decline         :   12.96
		Price                 :    0.00
		Price % of 52wk High  :    0.00
		Earnings weakness     :    5.00

Rank : 23
 INSW
	International Seaways Inc : NEW YORK, NY
	Energy, Oil & Gas - Transportation Services
	Employees     :        1,642
	OpInc per Emp : $   -101,583
	10Q Date      :  31-Mar-2019

	Market Cap        :        557.15 M
	Shares            :         29.18 M (Seq=    0.09% : QoQ=    0.26%)

	Sales 12m         :      1,279.10 M (Seq=   18.45% : QoQ=  -35.63%)
	Ops Income 12m    :       -166.80 M (Seq=   82.26% : QoQ= -105.80%)
	Net Income 12m    :       -261.90 M (Seq=   45.22% : QoQ= -128.12%)
	Interest Paid 12m :        207.10 M (Seq=    9.80% : QoQ=   53.72%)

	Cash <- Ops 12m   :         16.00 M (Seq=  267.83% : QoQ=  633.33%)
	  CapEx 12m       :          1.10 M (Seq=  -87.50% : QoQ=    0.00%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :         14.90 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :        -37.70 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :        -21.70 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :         67.60 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :         45.90 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        192.50 M (Seq=   14.86% : QoQ=   59.75%)
	  Cash            :         79.50 M (Seq=   36.36% : QoQ=   48.60%)
	  Acct Rx         :         99.70 M (Seq=   -0.20% : QoQ=   87.05%)
	  ST Invest       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Inventory       :          4.10 M (Seq=   32.26% : QoQ=    2.50%)
	  Other           :          9.20 M (Seq=   43.75% : QoQ=   -6.12%)
	Current Liabs     :        100.50 M (Seq=   33.47% : QoQ=  121.37%)
	  Acct Pay        :         33.20 M (Seq=   44.35% : QoQ=   34.41%)
	  ST Debt         :         57.70 M (Seq=   11.82% : QoQ=  180.10%)
	  Other           :          9.50 M (Seq= 1,257.14% : QoQ=    0.00%)
	Working Capital   :         92.00 M (Ratio=1.92)
	WC + FCF          :        106.90 M

	Sharehldr Equity  :      1,018.00 M (Seq=    0.80% : QoQ=   -4.29%)
	Tangible Assets   :      1,891.10 M (Seq=    2.30% : QoQ=   17.28%)
	LT Debt           :        748.00 M (Seq=   -1.46% : QoQ=   49.42%)
	LT Debt to Equity :          0.73

	Last Price          :       19.11 : (52wkHi= 24.15 %offHigh=20%)
	PE                  :      275.00
	Op Margin           :      -13.04%
	Net Margin          :      -20.48%
	ROE                 :      -25.73%
	Interest % of sales :       16.19%
	Q0 Est Growth       :      136.15%
	Y1 Est Growth       :      300.00%

	INSW State -->
	  Interest payments to sales is high at 16.19%.

	Zombie Score : 87.04
		Negative Sales        :   35.00
		Margins               :    3.35
		Available Cash to MC  :    0.00
		Interest Paid         :   16.19
		LT Debt to Equity     :    0.00
		Equity to MC          :    0.00
		OpsInc Growth 3Yr     :   32.50 : (-32.50%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00

Rank : 24
 SPWR
	SunPower Corporation : SAN JOSE, CA
	Energy, Renewable Energy Equipment & Services
	Employees     :        6,600
	OpInc per Emp : $   -466,424
	10Q Date      :  31-Mar-2019

	Market Cap        :      1,712.78 M
	Shares            :        141.72 M (Seq=    0.42% : QoQ=    1.08%)

	Sales 12m         :      7,755.10 M (Seq=   -2.53% : QoQ=    6.72%)
	Ops Income 12m    :     -3,078.40 M (Seq=    1.93% : QoQ= -303.59%)
	Net Income 12m    :     -2,973.60 M (Seq=    3.24% : QoQ= -319.68%)
	Interest Paid 12m :        359.30 M (Seq=   -7.69% : QoQ=  127.63%)

	Cash <- Ops 12m   :       -459.10 M (Seq= -466.54% : QoQ=   36.13%)
	  CapEx 12m       :         42.50 M (Seq=   -9.72% : QoQ=  -26.97%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :       -501.60 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :         69.70 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :       -389.40 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :        262.00 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :       -127.40 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :      1,490.10 M (Seq=   38.77% : QoQ=   23.66%)
	  Cash            :        185.60 M (Seq=  -40.01% : QoQ=  -28.81%)
	  Acct Rx         :        262.90 M (Seq=  -10.03% : QoQ=  -15.41%)
	  ST Invest       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Inventory       :        334.40 M (Seq=    8.54% : QoQ=   -5.70%)
	  Other           :        707.30 M (Seq=  331.02% : QoQ=  153.60%)
	Current Liabs     :      1,299.80 M (Seq=   84.37% : QoQ=   34.74%)
	  Acct Pay        :        347.20 M (Seq=    6.63% : QoQ=    3.89%)
	  ST Debt         :         41.80 M (Seq=    4.24% : QoQ=  -88.37%)
	  Other           :        910.80 M (Seq=  168.36% : QoQ=  235.96%)
	Working Capital   :        190.30 M (Ratio=1.15)
	WC + FCF          :       -311.30 M

	Sharehldr Equity  :       -286.40 M (Seq=  -37.23% : QoQ= -160.02%)
	Tangible Assets   :      2,296.80 M (Seq=   -1.85% : QoQ=  -38.90%)
	LT Debt           :        890.40 M (Seq=  -38.27% : QoQ=  -48.80%)
	LT Debt Tan Asset :          0.39

	Last Price          :       12.13 : (52wkHi= 12.79 %offHigh=5%)
	PE                  :      275.00
	Op Margin           :      -39.70%
	Net Margin          :      -38.34%
	ROE                 :        0.00%
	Interest % of sales :        4.63%
	Q0 Est Growth       :      265.54%
	Y1 Est Growth       :      282.71%

	SPWR State -->
	  Free Cash Flow plus Working Capital is negative (-311.30)
	  Shareholders have no equity.

	Zombie Score : 84.85
		Negative Sales        :    0.00
		Margins               :    7.80
		Available Cash to MC  :   15.69
		Interest Paid         :    4.63
		LT Debt to Equity     :    5.00
		Equity to MC          :   16.72
		OpsInc Growth 3Yr     :   35.00 : (-60.30%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00

Rank : 25
 REV
	Revlon Inc : NEW YORK, NY
	Non-Cyclicals, Personal Products
	Employees     :        7,300
	OpInc per Emp : $     -2,178
	10Q Date      :  31-Mar-2019

	Market Cap        :      1,075.11 M
	Shares            :         52.91 M (Seq=    0.11% : QoQ=    0.45%)

	Sales 12m         :     10,149.20 M (Seq=   -0.29% : QoQ=   33.57%)
	Ops Income 12m    :        -15.90 M (Seq=   45.07% : QoQ= -121.69%)
	Net Income 12m    :       -778.30 M (Seq=    5.17% : QoQ= -597.33%)
	Interest Paid 12m :        649.20 M (Seq=    5.04% : QoQ=  122.36%)

	Cash <- Ops 12m   :       -101.90 M (Seq= -122.56% : QoQ=   70.81%)
	  CapEx 12m       :         49.30 M (Seq=  -62.82% : QoQ=  -57.66%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :       -151.20 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :        172.10 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :         70.20 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :        -49.30 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :         20.90 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :      1,141.20 M (Seq=   -4.41% : QoQ=    2.41%)
	  Cash            :         68.30 M (Seq=  -21.76% : QoQ=   22.62%)
	  Acct Rx         :        378.50 M (Seq=  -12.24% : QoQ=   -0.68%)
	  ST Invest       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Inventory       :        546.70 M (Seq=    4.49% : QoQ=    6.05%)
	  Other           :        147.70 M (Seq=   -2.83% : QoQ=   -8.83%)
	Current Liabs     :      1,131.90 M (Seq=    1.03% : QoQ=   12.18%)
	  Acct Pay        :        355.70 M (Seq=    7.11% : QoQ=    2.98%)
	  ST Debt         :        399.00 M (Seq=   11.64% : QoQ=   50.51%)
	  Other           :        377.20 M (Seq=  -12.46% : QoQ=   -5.35%)
	Working Capital   :          9.30 M (Ratio=1.01)
	WC + FCF          :       -141.90 M

	Sharehldr Equity  :     -1,132.20 M (Seq=   -7.13% : QoQ=  -32.31%)
	Tangible Assets   :      1,852.20 M (Seq=    2.28% : QoQ=    4.96%)
	LT Debt           :      2,724.40 M (Seq=   -0.12% : QoQ=    2.75%)
	LT Debt Tan Asset :          1.47

	Last Price          :       20.34 : (52wkHi= 29.62 %offHigh=31%)
	PE                  :      275.00
	Op Margin           :       -0.16%
	Net Margin          :       -7.67%
	ROE                 :        0.00%
	Interest % of sales :        6.40%
	Q0 Est Growth       :      177.66%
	Y1 Est Growth       :      155.14%

	REV State -->
	  Free Cash Flow plus Working Capital is negative (-141.90)
	  Running company with Financing. Cash from Financing greater than FCF plus Working Capital.
	  Shareholders have no equity.

	Zombie Score : 84.59
		Negative Sales        :    0.00
		Margins               :    0.78
		Available Cash to MC  :    8.61
		Interest Paid         :    6.40
		LT Debt to Equity     :    5.00
		Equity to MC          :   30.00
		OpsInc Growth 3Yr     :   33.80 : (-33.80%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00

Rank : 26
 CZR
	Caesars Entertainment Corp : LAS VEGAS, NV
	Consumer Cyclicals, Casinos & Gaming, SP400
	Employees     :       66,000
	OpInc per Emp : $    -87,681
	10Q Date      :  31-Mar-2019

	Market Cap        :      8,137.41 M
	Shares            :        670.00 M (Seq=    0.30% : QoQ=   -3.87%)
	Share Change 12m  :        -27.00 M (Buyback Est= $243.81M)

	Sales 12m         :     25,670.00 M (Seq=    1.70% : QoQ=  117.21%)
	Ops Income 12m    :     -5,787.00 M (Seq=   -9.35% : QoQ=  -89.58%)
	Net Income 12m    :     -2,993.00 M (Seq=  -60.40% : QoQ=  -98.00%)
	Interest Paid 12m :      4,083.00 M (Seq=    1.41% : QoQ=   -0.15%)

	Cash <- Ops 12m   :      1,019.00 M (Seq=  171.28% : QoQ= 1,059.09%)
	  CapEx 12m       :        698.00 M (Seq=   -2.24% : QoQ=  156.47%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :        321.00 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :        175.00 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :      1,194.00 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :     -2,270.00 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :     -1,076.00 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :      2,191.00 M (Seq=   -3.27% : QoQ=  -34.07%)
	  Cash            :      1,395.00 M (Seq=   -6.44% : QoQ=  -43.86%)
	  Acct Rx         :        449.00 M (Seq=   -1.75% : QoQ=    2.28%)
	  ST Invest       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Inventory       :         39.00 M (Seq=   -4.88% : QoQ=   -7.14%)
	  Other           :        308.00 M (Seq=   11.59% : QoQ=  -13.73%)
	Current Liabs     :      1,963.00 M (Seq=   -1.85% : QoQ=   15.67%)
	  Acct Pay        :        411.00 M (Seq=    3.01% : QoQ=   71.97%)
	  ST Debt         :         85.00 M (Seq=  -53.80% : QoQ=   14.86%)
	  Other           :      1,467.00 M (Seq=    3.53% : QoQ=    6.00%)
	Working Capital   :        228.00 M (Ratio=1.12)
	WC + FCF          :        549.00 M

	Sharehldr Equity  :      3,039.00 M (Seq=   -6.49% : QoQ=   -5.33%)
	Tangible Assets   :     19,031.00 M (Seq=    1.48% : QoQ=   -3.58%)
	LT Debt           :     18,779.00 M (Seq=   -0.42% : QoQ=    3.04%)
	LT Debt to Equity :          6.18

	Last Price          :       11.98 : (52wkHi= 12.23 %offHigh=2%)
	PE                  :      275.00
	Op Margin           :      -22.54%
	Net Margin          :      -11.66%
	ROE                 :      -98.49%
	Interest % of sales :       15.91%
	Q0 Est Growth       :      116.33%
	Y1 Est Growth       :     -300.00%

	CZR State -->
	  Interest payments to sales is high at 15.91%.
	  LT debt to equity of 6.18 is high.

	Zombie Score : 84.46
		Negative Sales        :    0.00
		Margins               :    3.42
		Available Cash to MC  :    0.00
		Interest Paid         :   15.91
		LT Debt to Equity     :   15.45
		Equity to MC          :    0.00
		OpsInc Growth 3Yr     :   35.00 : (-51.40%)
		Share Decline         :    9.68
		Price                 :    0.00
		Price % of 52wk High  :    0.00
		Earnings weakness     :    5.00

Rank : 27
 TGTX
	TG Therapeutics Inc : NEW YORK, NY
	Healthcare, Biotechnology & Medical Research
	Employees     :          102
	OpInc per Emp : $ -4,267,647
	10Q Date      :  31-Mar-2019

	Market Cap        :        636.35 M
	Shares            :         81.17 M (Seq=    3.18% : QoQ=   14.92%)

	Sales 12m         :          0.80 M (Seq=    0.00% : QoQ=    0.00%)
	Ops Income 12m    :       -435.30 M (Seq=  -46.93% : QoQ= -213.11%)
	Net Income 12m    :       -537.40 M (Seq=    3.69% : QoQ= -165.66%)
	Interest Paid 12m :          1.00 M (Seq=    0.00% : QoQ= -100.00%)

	Cash <- Ops 12m   :       -134.30 M (Seq=    0.89% : QoQ=  -19.29%)
	  CapEx 12m       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :       -134.30 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :        118.10 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :        -16.20 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :         -1.70 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :        -17.90 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        105.10 M (Seq=   33.04% : QoQ=  -10.17%)
	  Cash            :         64.30 M (Seq=   53.10% : QoQ=  -22.44%)
	  Acct Rx         :          0.10 M (Seq=    0.00% : QoQ=    0.00%)
	  ST Invest       :         28.10 M (Seq=    4.85% : QoQ=    7.25%)
	  Inventory       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :         12.60 M (Seq=   24.75% : QoQ=   61.54%)
	Current Liabs     :         60.90 M (Seq=   56.56% : QoQ=   82.88%)
	  Acct Pay        :         40.20 M (Seq=   10.44% : QoQ=   23.69%)
	  ST Debt         :          0.10 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :         20.70 M (Seq=  762.50% : QoQ= 3,350.00%)
	Working Capital   :         44.20 M (Ratio=1.73)
	WC + FCF          :        -90.10 M

	Sharehldr Equity  :         19.30 M (Seq=  -19.58% : QoQ=  -77.35%)
	Tangible Assets   :        116.70 M (Seq=   40.94% : QoQ=   -2.91%)
	LT Debt           :         28.30 M (Seq=    0.00% : QoQ=    0.00%)
	LT Debt to Equity :          1.47

	Last Price          :        8.15 : (52wkHi= 13.71 %offHigh=40%)
	PE                  :      275.00
	Op Margin           :  -54,412.50%
	Net Margin          :  -67,175.00%
	ROE                 :   -2,784.46%
	Interest % of sales :      125.00%
	Q0 Est Growth       :       92.35%
	Y1 Est Growth       :       94.21%

	TGTX State -->
	  Free Cash Flow plus Working Capital is negative (-90.10)
	  Running company with Financing. Cash from Financing greater than FCF plus Working Capital.
	  Interest payments to sales is high at 125.00%.

	Zombie Score : 84.16
		Negative Sales        :    0.00
		Margins               :   35.00
		Available Cash to MC  :   14.16
		Interest Paid         :   35.00
		LT Debt to Equity     :    0.00
		Equity to MC          :    0.00
		OpsInc Growth 3Yr     :   35.00 : (-40.30%)
		Share Decline         :    0.00
		Price                 :  -35.00
		Price % of 52wk High  :    0.00

Rank : 28
 AAL
	American Airlines Group Inc : FORT WORTH, TX
	Industrials, Airlines, SP500
	Employees     :      128,900
	OpInc per Emp : $    112,854
	10Q Date      :  31-Mar-2019

	Market Cap        :     15,124.38 M
	Shares            :        451.95 M (Seq=   -1.88% : QoQ=   -4.31%)
	Share Change 12m  :        -20.35 M (Buyback Est= $721.47M)

	Sales 12m         :    172,029.00 M (Seq=    0.41% : QoQ=    9.11%)
	Ops Income 12m    :     14,547.00 M (Seq=   -2.11% : QoQ=  -58.09%)
	Net Income 12m    :      6,688.00 M (Seq=   -0.14% : QoQ=  -81.47%)
	Interest Paid 12m :      6,207.00 M (Seq=    0.66% : QoQ=   20.80%)

	Cash <- Ops 12m   :      3,385.00 M (Seq=  126.47% : QoQ=   -8.23%)
	  CapEx 12m       :      4,271.00 M (Seq=   29.34% : QoQ=   67.52%)
	  Dividends 12m   :        734.64 M (Yield=4.86%)
	    FCF 12m       :     -1,620.64 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :     -1,940.00 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :      1,445.00 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :     -1,497.00 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :        -52.00 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :      8,654.00 M (Seq=    0.20% : QoQ=  -10.53%)
	  Cash            :        337.00 M (Seq=   22.55% : QoQ=   13.47%)
	  Acct Rx         :      1,876.00 M (Seq=    9.96% : QoQ=    3.70%)
	  ST Invest       :      4,012.00 M (Seq=  -10.55% : QoQ=  -19.66%)
	  Inventory       :      1,666.00 M (Seq=    9.46% : QoQ=   14.50%)
	  Other           :        763.00 M (Seq=   17.57% : QoQ=  -31.75%)
	Current Liabs     :     19,849.00 M (Seq=    9.69% : QoQ=   16.70%)
	  Acct Pay        :      2,139.00 M (Seq=   20.64% : QoQ=    9.52%)
	  ST Debt         :      3,370.00 M (Seq=    2.31% : QoQ=   20.66%)
	  Other           :     14,340.00 M (Seq=   10.06% : QoQ=   16.95%)
	Working Capital   :    -11,195.00 M (Ratio=0.44)
	WC + FCF          :    -12,815.64 M

	Sharehldr Equity  :       -636.00 M (Seq= -276.33% : QoQ=   37.52%)
	Tangible Assets   :     54,581.00 M (Seq=    0.42% : QoQ=   16.14%)
	LT Debt           :     20,660.00 M (Seq=   -2.45% : QoQ=   -5.86%)
	LT Debt Tan Asset :          0.38

	Last Price          :       32.94 : (52wkHi= 43.89 %offHigh=24%)
	PE                  :        2.19
	Op Margin           :        8.46%
	Net Margin          :        3.89%
	ROE                 :        0.00%
	Interest % of sales :        3.61%
	EPS Yield           :       45.58% ($15.01)
	Q0 Est Growth       :      300.00%
	Y1 Est Growth       :      207.79%

	AAL State -->
	  Free Cash Flow plus Working Capital is negative (-12815.64) with dividend paid 734.64.
	  Current Ratio less than 0.75 and Cash Flow less than 0.
	  Shareholders have no equity.

	Zombie Score : 83.18
		Negative Sales        :    0.00
		Margins               :    0.00
		Available Cash to MC  :   35.00
		Interest Paid         :    3.61
		LT Debt to Equity     :    5.00
		Equity to MC          :    4.21
		OpsInc Growth 3Yr     :   24.60 : (-24.60%)
		Share Decline         :   10.77
		Price                 :    0.00
		Price % of 52wk High  :    0.00

Rank : 29
 ATNX
	Athenex Inc : BUFFALO, NY
	Healthcare, Biotechnology & Medical Research
	Employees     :          575
	OpInc per Emp : $   -827,304
	10Q Date      :  31-Mar-2019

	Market Cap        :      1,384.22 M
	Shares            :         67.01 M (Seq=    0.10% : QoQ=    8.69%)

	Sales 12m         :        224.30 M (Seq=  -14.03% : QoQ=  451.08%)
	Ops Income 12m    :       -475.70 M (Seq=  -20.82% : QoQ= -202.17%)
	Net Income 12m    :       -481.70 M (Seq=  -23.85% : QoQ= -187.35%)
	Interest Paid 12m :          9.60 M (Seq=  -69.49% : QoQ=    0.00%)

	Cash <- Ops 12m   :       -129.70 M (Seq=    3.23% : QoQ= -159.84%)
	  CapEx 12m       :          3.10 M (Seq=   12.50% : QoQ=  -25.00%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :       -132.80 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :        101.10 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :        -28.60 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :         60.00 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :         31.40 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        150.70 M (Seq=  -11.77% : QoQ=    7.57%)
	  Cash            :         71.00 M (Seq=   42.57% : QoQ=   81.12%)
	  Acct Rx         :         20.60 M (Seq=   58.46% : QoQ=  164.10%)
	  ST Invest       :          0.30 M (Seq=  -99.48% : QoQ=  -99.55%)
	  Inventory       :         25.20 M (Seq=  -12.50% : QoQ=   35.48%)
	  Other           :         33.60 M (Seq=   54.84% : QoQ=  366.67%)
	Current Liabs     :         67.70 M (Seq=   30.95% : QoQ=   84.97%)
	  Acct Pay        :         20.40 M (Seq=   56.92% : QoQ=   25.93%)
	  ST Debt         :          1.70 M (Seq=   70.00% : QoQ=   41.67%)
	  Other           :         45.60 M (Seq=   20.95% : QoQ=  137.50%)
	Working Capital   :         83.00 M (Ratio=2.23)
	WC + FCF          :        -49.80 M

	Sharehldr Equity  :        107.20 M (Seq=  -23.10% : QoQ=  -31.02%)
	Tangible Assets   :        172.30 M (Seq=   -5.74% : QoQ=   13.88%)
	LT Debt           :         46.00 M (Seq=    0.44% : QoQ= 11,400.00%)
	LT Debt to Equity :          0.43

	Last Price          :       21.00 : (52wkHi= 21.11 %offHigh=0%)
	PE                  :      275.00
	Op Margin           :     -212.08%
	Net Margin          :     -214.76%
	ROE                 :     -449.35%
	Interest % of sales :        4.28%
	Q0 Est Growth       :     -300.00%
	Y1 Est Growth       :        3.80%

	ATNX State -->
	  Free Cash Flow plus Working Capital is negative (-49.80)
	  Running company with Financing. Cash from Financing greater than FCF plus Working Capital.

	Zombie Score : 82.65
		Negative Sales        :    0.00
		Margins               :   35.00
		Available Cash to MC  :    3.37
		Interest Paid         :    4.28
		LT Debt to Equity     :    0.00
		Equity to MC          :    0.00
		OpsInc Growth 3Yr     :   35.00 : (-35.70%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00
		Earnings weakness     :    5.00

Rank : 30
 SILK
	Silk Road Medical Inc : SUNNYVALE, CA
	Healthcare, Medical Equipment, Supplies & Distribution
	Employees     :          176
	OpInc per Emp : $   -226,136
	10Q Date      :  31-Mar-2019

	Market Cap        :        318.24 M
	Shares            :         30.20 M (Seq=    0.00% : QoQ=    0.00%)

	Sales 12m         :         48.90 M (Seq=  141.96% : QoQ=    0.00%)
	Ops Income 12m    :        -39.80 M (Seq=  -16.30% : QoQ=    0.00%)
	Net Income 12m    :        -57.00 M (Seq=  -93.81% : QoQ=    0.00%)
	Interest Paid 12m :          8.30 M (Seq=   12.82% : QoQ=    0.00%)

	Cash <- Ops 12m   :         -8.60 M (Seq=    0.00% : QoQ=    0.00%)
	  CapEx 12m       :          0.10 M (Seq=    0.00% : QoQ=    0.00%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :         -8.70 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :         -0.70 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :         -9.30 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :         -0.10 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :         -9.40 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :         29.10 M (Seq=    0.00% : QoQ=    0.00%)
	  Cash            :         15.50 M (Seq=    0.00% : QoQ=    0.00%)
	  Acct Rx         :          4.10 M (Seq=    0.00% : QoQ=    0.00%)
	  ST Invest       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Inventory       :          8.10 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :          1.40 M (Seq=    0.00% : QoQ=    0.00%)
	Current Liabs     :         10.80 M (Seq=    0.00% : QoQ=    0.00%)
	  Acct Pay        :          3.10 M (Seq=    0.00% : QoQ=    0.00%)
	  ST Debt         :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :          7.70 M (Seq=    0.00% : QoQ=    0.00%)
	Working Capital   :         18.30 M (Ratio=2.69)
	WC + FCF          :          9.60 M

	Sharehldr Equity  :       -158.10 M (Seq=    0.00% : QoQ=    0.00%)
	Tangible Assets   :         38.70 M (Seq=    0.00% : QoQ=    0.00%)
	LT Debt           :         44.60 M (Seq=    0.00% : QoQ=    0.00%)
	LT Debt Tan Asset :          1.15

	Last Price          :       42.15 : (52wkHi= 51.50 %offHigh=18%)
	PE                  :      275.00
	Op Margin           :      -81.39%
	Net Margin          :     -116.56%
	ROE                 :        0.00%
	Interest % of sales :       16.97%
	Q0 Est Growth       :     -157.54%
	Y1 Est Growth       :      -97.59%

	SILK State -->
	  Interest payments to sales is high at 16.97%.
	  Shareholders have no equity.

	Zombie Score : 81.77
		Negative Sales        :    0.00
		Margins               :   19.80
		Available Cash to MC  :    0.00
		Interest Paid         :   16.97
		LT Debt to Equity     :    5.00
		Equity to MC          :   30.00
		OpsInc Growth 3Yr     :    0.00 : (0.00%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00
		Earnings weakness     :   10.00

Rank : 31
 TDW
	Tidewater Inc. : HOUSTON, TX
	Energy, Oil & Gas - Related Services And Equipment
	Employees     :        5,500
	OpInc per Emp : $   -450,127
	10Q Date      :  31-Mar-2019

	Market Cap        :        674.63 M
	Shares            :         37.18 M (Seq=   19.39% : QoQ=   58.72%)

	Sales 12m         :      1,775.40 M (Seq=    7.55% : QoQ=  -55.35%)
	Ops Income 12m    :     -2,475.70 M (Seq=    2.16% : QoQ=  -62.73%)
	Net Income 12m    :     -2,671.90 M (Seq=   10.15% : QoQ=    3.81%)
	Interest Paid 12m :        160.20 M (Seq=    0.66% : QoQ=  -43.12%)

	Cash <- Ops 12m   :          6.70 M (Seq=   82.51% : QoQ=   46.67%)
	  CapEx 12m       :         22.80 M (Seq=  -74.80% : QoQ=   82.35%)
	  Dividends 12m   :        695.32 M (Yield=103.07%)
	    FCF 12m       :       -711.42 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :       -121.40 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :       -114.70 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :         67.20 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :        -47.50 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        674.10 M (Seq=   -1.35% : QoQ=  -17.40%)
	  Cash            :        391.10 M (Seq=    5.19% : QoQ=  -11.62%)
	  Acct Rx         :        231.90 M (Seq=   -5.04% : QoQ=  -28.36%)
	  ST Invest       :          0.00 M (Seq=    0.00% : QoQ= -100.00%)
	  Inventory       :         29.30 M (Seq=   -0.68% : QoQ=    1.38%)
	  Other           :         21.80 M (Seq=  -42.33% : QoQ=   78.69%)
	Current Liabs     :        156.10 M (Seq=   -1.45% : QoQ=  -20.84%)
	  Acct Pay        :         29.70 M (Seq=   -6.90% : QoQ=  -35.15%)
	  ST Debt         :         10.00 M (Seq=   16.28% : QoQ=   92.31%)
	  Other           :        116.40 M (Seq=   -1.19% : QoQ=  -20.38%)
	Working Capital   :        518.00 M (Ratio=4.32)
	WC + FCF          :       -193.42 M

	Sharehldr Equity  :      1,126.20 M (Seq=   -1.54% : QoQ=   14.56%)
	Tangible Assets   :      1,809.30 M (Seq=   -1.01% : QoQ=    7.31%)
	LT Debt           :        427.40 M (Seq=   -0.70% : QoQ=   -3.46%)
	LT Debt to Equity :          0.38

	Last Price          :       22.86 : (52wkHi= 36.09 %offHigh=36%)
	PE                  :      275.00
	Op Margin           :     -139.44%
	Net Margin          :     -150.50%
	ROE                 :     -237.25%
	Interest % of sales :        9.02%
	Q0 Est Growth       :      210.29%
	Y1 Est Growth       :      259.35%

	TDW State -->
	  Free Cash Flow plus Working Capital is negative (-193.42) with dividend paid 695.32.

	Zombie Score : 81.52
		Negative Sales        :   35.00
		Margins               :   28.99
		Available Cash to MC  :    0.00
		Interest Paid         :    9.02
		LT Debt to Equity     :    0.00
		Equity to MC          :  -10.00
		OpsInc Growth 3Yr     :   18.50 : (-18.50%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00

Rank : 32
 DERM
	Dermira Inc : MENLO PARK, CA
	Healthcare, Biotechnology & Medical Research
	Employees     :          333
	OpInc per Emp : $ -2,476,576
	10Q Date      :  31-Mar-2019

	Market Cap        :        383.68 M
	Shares            :         43.59 M (Seq=    3.29% : QoQ=    4.20%)

	Sales 12m         :        113.90 M (Seq=    5.20% : QoQ=  509.59%)
	Ops Income 12m    :       -824.70 M (Seq=   -2.71% : QoQ= -175.44%)
	Net Income 12m    :       -841.00 M (Seq=   -2.53% : QoQ= -189.67%)
	Interest Paid 12m :         38.70 M (Seq=   -3.85% : QoQ= 14,900.00%)

	Cash <- Ops 12m   :       -226.90 M (Seq=   12.39% : QoQ=  -25.18%)
	  CapEx 12m       :          0.50 M (Seq=    0.00% : QoQ= -100.00%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :       -227.40 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :        175.00 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :        -51.90 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :        -35.00 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :        -86.90 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        443.00 M (Seq=   32.08% : QoQ=  -11.77%)
	  Cash            :        201.70 M (Seq=   92.10% : QoQ=  -30.11%)
	  Acct Rx         :          8.50 M (Seq=   49.12% : QoQ= 8,400.00%)
	  ST Invest       :        186.10 M (Seq=  -10.57% : QoQ=  -10.18%)
	  Inventory       :         13.40 M (Seq=   59.52% : QoQ=    0.00%)
	  Other           :         33.40 M (Seq=  302.41% : QoQ=  438.71%)
	Current Liabs     :         62.10 M (Seq=   60.88% : QoQ=  -36.05%)
	  Acct Pay        :          6.10 M (Seq=  -61.64% : QoQ=  -42.45%)
	  ST Debt         :          4.20 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :         51.80 M (Seq=  129.20% : QoQ=  -40.12%)
	Working Capital   :        380.90 M (Ratio=7.13)
	WC + FCF          :        153.50 M

	Sharehldr Equity  :         74.60 M (Seq=  928.89% : QoQ=  -41.67%)
	Tangible Assets   :        459.90 M (Seq=   34.24% : QoQ=   -8.95%)
	LT Debt           :        314.40 M (Seq=    0.19% : QoQ=   12.37%)
	LT Debt to Equity :          4.21

	Last Price          :        9.04 : (52wkHi= 15.48 %offHigh=41%)
	PE                  :      275.00
	Op Margin           :     -724.06%
	Net Margin          :     -738.37%
	ROE                 :   -1,127.35%
	Interest % of sales :       33.98%
	Q0 Est Growth       :       96.75%
	Y1 Est Growth       :        6.09%

	DERM State -->
	  Interest payments to sales is high at 33.98%.

	Zombie Score : 79.51
		Negative Sales        :    0.00
		Margins               :   35.00
		Available Cash to MC  :    0.00
		Interest Paid         :   33.98
		LT Debt to Equity     :   10.54
		Equity to MC          :    0.00
		OpsInc Growth 3Yr     :   35.00 : (-38.90%)
		Share Decline         :    0.00
		Price                 :  -35.00
		Price % of 52wk High  :    0.00

Rank : 33
 EVOP
	EVO Payments Inc : ATLANTA, GA
	Industrials, Business Support Services
	Employees     :        2,200
	OpInc per Emp : $     39,363
	10Q Date      :  31-Mar-2019

	Market Cap        :        676.22 M
	Shares            :         26.37 M (Seq=  -13.90% : QoQ=   52.47%)

	Sales 12m         :      2,036.80 M (Seq=   -2.97% : QoQ=   54.15%)
	Ops Income 12m    :         86.60 M (Seq=  -42.86% : QoQ= -184.68%)
	Net Income 12m    :        -27.20 M (Seq=  -36.05% : QoQ= -160.98%)
	Interest Paid 12m :        219.50 M (Seq=   -6.19% : QoQ=  168.42%)

	Cash <- Ops 12m   :         83.50 M (Seq= -188.14% : QoQ= -11,860.00%)
	  CapEx 12m       :         46.70 M (Seq=  -33.67% : QoQ=  -24.42%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :         36.80 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :         59.60 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :        143.10 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :       -123.90 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :         19.20 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        945.30 M (Seq=   36.74% : QoQ=   18.85%)
	  Cash            :        221.10 M (Seq=  -36.95% : QoQ=    0.45%)
	  Acct Rx         :         71.10 M (Seq=   -0.70% : QoQ=  -10.00%)
	  ST Invest       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Inventory       :          9.50 M (Seq=    6.74% : QoQ=    2.15%)
	  Other           :        643.70 M (Seq=  147.48% : QoQ=   32.18%)
	Current Liabs     :        901.80 M (Seq=   40.16% : QoQ=   15.48%)
	  Acct Pay        :         51.20 M (Seq=    4.70% : QoQ=    7.56%)
	  ST Debt         :         58.10 M (Seq=   18.57% : QoQ=  -44.72%)
	  Other           :        792.60 M (Seq=   45.32% : QoQ=   26.17%)
	Working Capital   :         43.50 M (Ratio=1.05)
	WC + FCF          :         80.30 M

	Sharehldr Equity  :       -193.30 M (Seq= -297.74% : QoQ=   -2.17%)
	Tangible Assets   :      1,141.10 M (Seq=   28.04% : QoQ=   22.82%)
	LT Debt           :        677.70 M (Seq=    0.12% : QoQ=  -15.89%)
	LT Debt Tan Asset :          0.59

	Last Price          :       29.26 : (52wkHi= 31.83 %offHigh=8%)
	PE                  :      275.00
	Op Margin           :        4.25%
	Net Margin          :       -1.34%
	ROE                 :        0.00%
	Interest % of sales :       10.78%
	Q0 Est Growth       :      300.00%
	Y1 Est Growth       :      300.00%

	EVOP State -->
	  Shareholders have no equity.

	Zombie Score : 79.36
		Negative Sales        :    0.00
		Margins               :    0.00
		Available Cash to MC  :    0.00
		Interest Paid         :   10.78
		LT Debt to Equity     :    5.00
		Equity to MC          :   28.59
		OpsInc Growth 3Yr     :   35.00 : (-37.40%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00

Rank : 34
 QCOM
	QUALCOMM, Inc. : SAN DIEGO, CA
	Technology, Semiconductors, SP500
	Employees     :       35,400
	OpInc per Emp : $    316,271
	10Q Date      :  31-Mar-2019

	Market Cap        :     98,880.21 M
	Shares            :      1,213.00 M (Seq=    0.00% : QoQ=  -18.15%)
	Share Change 12m  :       -269.00 M (Buyback Est= $18,754.68M)

	Sales 12m         :     89,804.00 M (Seq=   -6.62% : QoQ=  -16.04%)
	Ops Income 12m    :     11,196.00 M (Seq=  176.88% : QoQ=  -68.33%)
	Net Income 12m    :      5,764.00 M (Seq=  150.51% : QoQ=  -53.39%)
	Interest Paid 12m :      2,296.00 M (Seq=   -4.04% : QoQ=  608.65%)

	Cash <- Ops 12m   :      2,767.00 M (Seq=  147.43% : QoQ=   58.72%)
	  CapEx 12m       :        695.00 M (Seq=   11.84% : QoQ=   -8.11%)
	  Dividends 12m   :     12,140.62 M (Yield=12.28%)
	    FCF 12m       :    -10,068.62 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :    -33,144.00 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :    -30,377.00 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :      2,639.00 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :    -27,738.00 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :     16,324.00 M (Seq=    0.18% : QoQ=  -64.16%)
	  Cash            :     10,135.00 M (Seq=    0.69% : QoQ=  -73.29%)
	  Acct Rx         :      3,638.00 M (Seq=    6.19% : QoQ=    2.91%)
	  ST Invest       :        195.00 M (Seq=  -21.69% : QoQ=  -88.00%)
	  Inventory       :      1,725.00 M (Seq=    1.59% : QoQ=   -4.01%)
	  Other           :        631.00 M (Seq=  -26.20% : QoQ=   -1.56%)
	Current Liabs     :     10,517.00 M (Seq=   -0.37% : QoQ=  -16.93%)
	  Acct Pay        :      1,667.00 M (Seq=   17.23% : QoQ=   14.65%)
	  ST Debt         :        998.00 M (Seq=    0.00% : QoQ=  -73.27%)
	  Other           :      7,852.00 M (Seq=   -3.49% : QoQ=    5.07%)
	Working Capital   :      5,807.00 M (Ratio=1.55)
	WC + FCF          :     -4,261.62 M

	Sharehldr Equity  :      3,866.00 M (Seq=    6.88% : QoQ=  -83.77%)
	Tangible Assets   :     25,214.00 M (Seq=    0.04% : QoQ=  -53.32%)
	LT Debt           :     15,405.00 M (Seq=    0.11% : QoQ=  -20.43%)
	LT Debt to Equity :          3.98

	Last Price          :       74.36 : (52wkHi= 90.34 %offHigh=17%)
	PE                  :       17.50
	Op Margin           :       12.47%
	Net Margin          :        6.42%
	ROE                 :      149.09%
	Interest % of sales :        2.56%
	EPS Yield           :        5.72% ($4.25)
	Q0 Est Growth       :      300.00%
	Y1 Est Growth       :      300.00%

	QCOM State -->
	  Free Cash Flow plus Working Capital is negative (-4261.62) with dividend paid 12140.62.

	Zombie Score : 78.55
		Negative Sales        :   16.04
		Margins               :    0.00
		Available Cash to MC  :    0.00
		Interest Paid         :    2.56
		LT Debt to Equity     :    9.96
		Equity to MC          :    0.00
		OpsInc Growth 3Yr     :   35.00 : (-51.50%)
		Share Decline         :   15.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00

Rank : 35
 CATS
	Catasys, Inc. : LOS ANGELES, CA
	Healthcare, Healthcare Facilities & Services
	Employees     :          209
	OpInc per Emp : $   -223,444
	10Q Date      :  31-Mar-2019

	Market Cap        :        302.01 M
	Shares            :         16.20 M (Seq=    0.65% : QoQ=    1.89%)

	Sales 12m         :         50.10 M (Seq=   32.24% : QoQ=  644.44%)
	Ops Income 12m    :        -46.70 M (Seq=   12.50% : QoQ=  -29.35%)
	Net Income 12m    :        -58.60 M (Seq=    9.15% : QoQ=  -79.17%)
	Interest Paid 12m :         10.30 M (Seq=   50.00% : QoQ=  -65.38%)

	Cash <- Ops 12m   :         -9.50 M (Seq= -193.33% : QoQ=  -29.41%)
	  CapEx 12m       :          0.00 M (Seq=    0.00% : QoQ= -100.00%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :         -9.50 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :          9.90 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :          0.40 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :          0.10 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :          0.50 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :          5.80 M (Seq=    5.45% : QoQ=  100.00%)
	  Cash            :          1.30 M (Seq=  -59.38% : QoQ=   -7.14%)
	  Acct Rx         :          3.60 M (Seq=  157.14% : QoQ=  200.00%)
	  ST Invest       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Inventory       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :          0.90 M (Seq=    0.00% : QoQ=  125.00%)
	Current Liabs     :          8.50 M (Seq=   10.39% : QoQ=   80.85%)
	  Acct Pay        :          0.80 M (Seq=   60.00% : QoQ=   14.29%)
	  ST Debt         :          1.20 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :          6.50 M (Seq=   -9.72% : QoQ=   66.67%)
	Working Capital   :         -2.70 M (Ratio=0.68)
	WC + FCF          :        -12.20 M

	Sharehldr Equity  :        -10.70 M (Seq=  -18.89% : QoQ= -1,088.89%)
	Tangible Assets   :          7.20 M (Seq=   14.29% : QoQ=   89.47%)
	LT Debt           :          8.90 M (Seq=   18.67% : QoQ=    0.00%)
	LT Debt Tan Asset :          1.24

	Last Price          :       18.84 : (52wkHi= 20.83 %offHigh=9%)
	PE                  :      275.00
	Op Margin           :      -93.21%
	Net Margin          :     -116.97%
	ROE                 :        0.00%
	Interest % of sales :       20.56%
	Q0 Est Growth       :      -43.02%
	Y1 Est Growth       :      -22.22%

	CATS State -->
	  Cash from Operations less than Working Capital deficit
	  Free Cash Flow plus Working Capital is negative (-12.20)
	  Interest payments to sales is high at 20.56%.
	  Shareholders have no equity.

	Zombie Score : 78.26
		Negative Sales        :    0.00
		Margins               :   21.02
		Available Cash to MC  :    4.04
		Interest Paid         :   20.56
		LT Debt to Equity     :    5.00
		Equity to MC          :    3.54
		OpsInc Growth 3Yr     :   14.10 : (-14.10%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00
		Earnings weakness     :   10.00

Rank : 36
 OSTK
	Overstock.com Inc : MIDVALE, UT
	Technology, Online Services
	Employees     :        2,060
	OpInc per Emp : $   -131,504
	10Q Date      :  31-Mar-2019

	Market Cap        :        572.63 M
	Shares            :         32.37 M (Seq=    0.73% : QoQ=   13.32%)

	Sales 12m         :      7,110.40 M (Seq=   -4.26% : QoQ=    5.20%)
	Ops Income 12m    :       -270.90 M (Seq= -318.25% : QoQ= -2,156.07%)
	Net Income 12m    :       -297.10 M (Seq=  -91.32% : QoQ= -2,402.25%)
	Interest Paid 12m :          5.40 M (Seq=  -48.28% : QoQ=    0.00%)

	Cash <- Ops 12m   :       -190.30 M (Seq= -176.34% : QoQ= -403.92%)
	  CapEx 12m       :         32.70 M (Seq=  -48.75% : QoQ=    2.50%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :       -223.00 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :        218.00 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :         27.70 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :       -109.20 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :        -81.50 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        185.00 M (Seq=  -14.07% : QoQ=  -41.68%)
	  Cash            :        119.60 M (Seq=  -15.48% : QoQ=  -53.93%)
	  Acct Rx         :         30.80 M (Seq=  -14.21% : QoQ=   41.28%)
	  ST Invest       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Inventory       :         13.60 M (Seq=   -3.55% : QoQ=    8.80%)
	  Other           :         20.90 M (Seq=  -11.81% : QoQ=  -10.68%)
	Current Liabs     :        202.00 M (Seq=  -16.36% : QoQ=   -9.70%)
	  Acct Pay        :         84.80 M (Seq=  -28.38% : QoQ=  -19.92%)
	  ST Debt         :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :        117.20 M (Seq=   -4.72% : QoQ=   -0.51%)
	Working Capital   :        -17.00 M (Ratio=0.92)
	WC + FCF          :       -240.00 M

	Sharehldr Equity  :        134.80 M (Seq=    2.35% : QoQ=  -25.07%)
	Tangible Assets   :        410.20 M (Seq=   -3.46% : QoQ=  -14.47%)
	LT Debt           :          3.10 M (Seq=    0.00% : QoQ=  -92.25%)
	LT Debt to Equity :          0.02

	Last Price          :       18.39 : (52wkHi= 48.00 %offHigh=61%)
	PE                  :      275.00
	Op Margin           :       -3.81%
	Net Margin          :       -4.18%
	ROE                 :     -220.40%
	Interest % of sales :        0.08%
	Q0 Est Growth       :      141.56%
	Y1 Est Growth       :      154.72%

	OSTK State -->
	  Cash from Operations less than Working Capital deficit
	  Free Cash Flow plus Working Capital is negative (-240.00)

	Zombie Score : 76.72
		Negative Sales        :    0.00
		Margins               :    0.80
		Available Cash to MC  :   35.00
		Interest Paid         :    0.08
		LT Debt to Equity     :    0.00
		Equity to MC          :    0.00
		OpsInc Growth 3Yr     :   35.00 : (-340.90%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    5.84

Rank : 37
 IRWD
	Ironwood Pharmaceuticals, Inc. : CAMBRIDGE, MA
	Healthcare, Biotechnology & Medical Research
	Employees     :          515
	OpInc per Emp : $ -1,218,640
	10Q Date      :  31-Mar-2019

	Market Cap        :      1,623.69 M
	Shares            :        154.96 M (Seq=    0.55% : QoQ=    2.61%)

	Sales 12m         :      1,265.10 M (Seq=   -0.12% : QoQ=  131.42%)
	Ops Income 12m    :       -627.60 M (Seq=   -7.74% : QoQ= -152.11%)
	Net Income 12m    :       -779.50 M (Seq=   -5.70% : QoQ= -109.18%)
	Interest Paid 12m :        151.30 M (Seq=    0.80% : QoQ=   22.19%)

	Cash <- Ops 12m   :        -82.40 M (Seq= -555.91% : QoQ=  -37.22%)
	  CapEx 12m       :         10.30 M (Seq=   -3.03% : QoQ=  113.33%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :        -92.70 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :         15.90 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :        -66.50 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :         41.20 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :        -25.30 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        201.80 M (Seq=  -24.25% : QoQ=  -26.80%)
	  Cash            :        119.00 M (Seq=  -31.29% : QoQ=  -17.82%)
	  Acct Rx         :         72.60 M (Seq=  -10.37% : QoQ=    2.69%)
	  ST Invest       :          0.00 M (Seq= -100.00% : QoQ= -100.00%)
	  Inventory       :          0.60 M (Seq=    0.00% : QoQ=  -64.71%)
	  Other           :          9.60 M (Seq=  -21.95% : QoQ=    7.87%)
	Current Liabs     :        118.60 M (Seq=   -0.75% : QoQ=   90.37%)
	  Acct Pay        :         11.20 M (Seq=  -38.12% : QoQ=   -3.45%)
	  ST Debt         :         46.00 M (Seq=   -3.36% : QoQ=  200.65%)
	  Other           :         61.40 M (Seq=   14.13% : QoQ=   73.45%)
	Working Capital   :         83.20 M (Ratio=1.70)
	WC + FCF          :         -9.50 M

	Sharehldr Equity  :       -237.20 M (Seq=  -20.77% : QoQ= -1,210.50%)
	Tangible Assets   :        362.70 M (Seq=    9.48% : QoQ=  -12.37%)
	LT Debt           :        360.10 M (Seq=   -1.69% : QoQ=   -7.29%)
	LT Debt Tan Asset :          0.99

	Last Price          :       10.57 : (52wkHi= 17.75 %offHigh=40%)
	PE                  :      275.00
	Op Margin           :      -49.61%
	Net Margin          :      -61.62%
	ROE                 :        0.00%
	Interest % of sales :       11.96%
	Q0 Est Growth       :      271.68%
	Y1 Est Growth       :      292.86%

	IRWD State -->
	  Free Cash Flow plus Working Capital is negative (-9.50)
	  Running company with Financing. Cash from Financing greater than FCF plus Working Capital.
	  Shareholders have no equity.

	Zombie Score : 75.49
		Negative Sales        :    0.00
		Margins               :   11.12
		Available Cash to MC  :    0.00
		Interest Paid         :   11.96
		LT Debt to Equity     :    5.00
		Equity to MC          :   14.61
		OpsInc Growth 3Yr     :   32.80 : (-32.80%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00

Rank : 38
 OPTN
	OptiNose Inc : YARDLEY, PA
	Healthcare, Biotechnology & Medical Research
	Employees     :           99
	OpInc per Emp : $ -2,239,393
	10Q Date      :  31-Mar-2019

	Market Cap        :        300.50 M
	Shares            :         41.26 M (Seq=   -0.06% : QoQ=    9.00%)

	Sales 12m         :         65.30 M (Seq=   50.70% : QoQ= 10,600.00%)
	Ops Income 12m    :       -221.70 M (Seq=    1.90% : QoQ= -249.82%)
	Net Income 12m    :       -272.10 M (Seq=    1.59% : QoQ= -159.90%)
	Interest Paid 12m :         23.00 M (Seq=    2.17% : QoQ= 1,075.00%)

	Cash <- Ops 12m   :        -98.50 M (Seq=  -47.03% : QoQ=  -29.13%)
	  CapEx 12m       :          1.50 M (Seq=    0.00% : QoQ=  -50.00%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :       -100.00 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :         61.50 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :        -37.00 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :         -1.50 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :        -38.50 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        186.80 M (Seq=  -12.26% : QoQ=  -13.96%)
	  Cash            :        171.30 M (Seq=  -14.78% : QoQ=  -18.35%)
	  Acct Rx         :          5.90 M (Seq=  126.92% : QoQ=  156.52%)
	  ST Invest       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Inventory       :          5.70 M (Seq=  -19.72% : QoQ=   58.33%)
	  Other           :          3.80 M (Seq=   72.73% : QoQ=  171.43%)
	Current Liabs     :         26.90 M (Seq=    4.67% : QoQ=   19.56%)
	  Acct Pay        :          7.70 M (Seq=    8.45% : QoQ=   -3.75%)
	  ST Debt         :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :         19.20 M (Seq=    3.23% : QoQ=   32.41%)
	Working Capital   :        159.90 M (Ratio=6.94)
	WC + FCF          :         59.90 M

	Sharehldr Equity  :         92.40 M (Seq=  -22.09% : QoQ=  -26.72%)
	Tangible Assets   :        193.00 M (Seq=  -11.06% : QoQ=  -12.51%)
	LT Debt           :         72.70 M (Seq=    0.28% : QoQ=    0.97%)
	LT Debt to Equity :          0.79

	Last Price          :        7.40 : (52wkHi= 29.60 %offHigh=75%)
	PE                  :      275.00
	Op Margin           :     -339.51%
	Net Margin          :     -416.69%
	ROE                 :     -294.48%
	Interest % of sales :       35.22%
	Q0 Est Growth       :       27.48%
	Y1 Est Growth       :      -25.84%

	OPTN State -->
	  Interest payments to sales is high at 35.22%.

	Zombie Score : 75.00
		Negative Sales        :    0.00
		Margins               :   35.00
		Available Cash to MC  :    0.00
		Interest Paid         :   35.00
		LT Debt to Equity     :    0.00
		Equity to MC          :    0.00
		OpsInc Growth 3Yr     :   35.00 : (-52.80%)
		Share Decline         :    0.00
		Price                 :  -35.00
		Price % of 52wk High  :    0.00
		Earnings weakness     :    5.00

Rank : 39
 PHAS
	PhaseBio Pharmaceuticals Inc : MALVERN, PA
	Healthcare, Biotechnology & Medical Research
	Employees     :           24
	OpInc per Emp : $   -816,666
	10Q Date      :  31-Mar-2019

	Market Cap        :        271.33 M
	Shares            :         24.50 M (Seq=    0.00% : QoQ=    0.00%)

	Sales 12m         :          2.00 M (Seq=   85.71% : QoQ=    0.00%)
	Ops Income 12m    :        -19.60 M (Seq=    0.00% : QoQ=    0.00%)
	Net Income 12m    :        -43.20 M (Seq= -133.33% : QoQ=    0.00%)
	Interest Paid 12m :          6.60 M (Seq=   44.44% : QoQ=    0.00%)

	Cash <- Ops 12m   :        -25.70 M (Seq=  -27.94% : QoQ= -234.62%)
	  CapEx 12m       :          0.20 M (Seq=    0.00% : QoQ=    0.00%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :        -25.90 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :         64.50 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :         38.80 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :         -0.20 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :         38.60 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :         54.10 M (Seq=  -13.58% : QoQ=    0.00%)
	  Cash            :         51.90 M (Seq=  -14.92% : QoQ=    0.00%)
	  Acct Rx         :          0.70 M (Seq=  250.00% : QoQ=    0.00%)
	  ST Invest       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Inventory       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :          1.50 M (Seq=    7.14% : QoQ=    0.00%)
	Current Liabs     :          3.80 M (Seq=  -17.39% : QoQ=    0.00%)
	  Acct Pay        :          2.10 M (Seq=   16.67% : QoQ=    0.00%)
	  ST Debt         :          0.40 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :          1.30 M (Seq=  -53.57% : QoQ=    0.00%)
	Working Capital   :         50.30 M (Ratio=14.24)
	WC + FCF          :         24.40 M

	Sharehldr Equity  :         44.10 M (Seq=  -13.36% : QoQ=    0.00%)
	Tangible Assets   :         56.40 M (Seq=  -10.48% : QoQ=    0.00%)
	LT Debt           :          6.80 M (Seq=   -9.33% : QoQ=    0.00%)
	LT Debt to Equity :          0.15

	Last Price          :       11.66 : (52wkHi= 16.65 %offHigh=29%)
	PE                  :        4.57
	Op Margin           :     -980.00%
	Net Margin          :   -2,160.00%
	ROE                 :      -97.96%
	Interest % of sales :      330.00%
	EPS Yield           :       21.89% ($2.55)
	Q0 Est Growth       :      283.79%
	Y1 Est Growth       :     -105.76%

	PHAS State -->
	  Interest payments to sales is high at 330.00%.

	Zombie Score : 75.00
		Negative Sales        :    0.00
		Margins               :   35.00
		Available Cash to MC  :    0.00
		Interest Paid         :   35.00
		LT Debt to Equity     :    0.00
		Equity to MC          :    0.00
		OpsInc Growth 3Yr     :    0.00 : (0.00%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00
		Earnings weakness     :    5.00

Rank : 40
 RDUS
	Radius Health Inc : WALTHAM, MA
	Healthcare, Biotechnology & Medical Research
	Employees     :          398
	OpInc per Emp : $ -1,601,758
	10Q Date      :  31-Mar-2019

	Market Cap        :      1,082.91 M
	Shares            :         45.67 M (Seq=    0.26% : QoQ=    1.63%)

	Sales 12m         :        235.80 M (Seq=   15.42% : QoQ=    0.00%)
	Ops Income 12m    :       -637.50 M (Seq=    9.65% : QoQ=    0.00%)
	Net Income 12m    :       -860.80 M (Seq=    8.50% : QoQ=  -99.51%)
	Interest Paid 12m :         54.70 M (Seq=    1.74% : QoQ= 1,131.58%)

	Cash <- Ops 12m   :       -169.00 M (Seq=   14.18% : QoQ=   50.85%)
	  CapEx 12m       :          0.20 M (Seq=    0.00% : QoQ=  116.67%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :       -169.20 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :          5.10 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :       -163.90 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :        179.90 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :         16.00 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        246.20 M (Seq=  -10.47% : QoQ=   -4.50%)
	  Cash            :         71.50 M (Seq=   20.57% : QoQ=   27.45%)
	  Acct Rx         :         20.80 M (Seq=   23.81% : QoQ=  160.00%)
	  ST Invest       :        132.70 M (Seq=  -25.07% : QoQ=  -26.07%)
	  Inventory       :          5.60 M (Seq=   -9.68% : QoQ=    3.70%)
	  Other           :         15.60 M (Seq=    0.00% : QoQ=   79.31%)
	Current Liabs     :         47.70 M (Seq=    2.80% : QoQ=   21.07%)
	  Acct Pay        :          9.90 M (Seq=  135.71% : QoQ=  120.00%)
	  ST Debt         :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :         37.80 M (Seq=  -10.43% : QoQ=    8.62%)
	Working Capital   :        198.50 M (Ratio=5.16)
	WC + FCF          :         29.30 M

	Sharehldr Equity  :         28.00 M (Seq=  -53.80% : QoQ=  -85.66%)
	Tangible Assets   :        257.70 M (Seq=   -7.83% : QoQ=  -34.92%)
	LT Debt           :        183.60 M (Seq=    2.11% : QoQ=    8.45%)
	LT Debt to Equity :          6.56

	Last Price          :       23.78 : (52wkHi= 30.54 %offHigh=22%)
	PE                  :      275.00
	Op Margin           :     -270.36%
	Net Margin          :     -365.06%
	ROE                 :   -3,074.29%
	Interest % of sales :       23.20%
	Q0 Est Growth       :      108.61%
	Y1 Est Growth       :       78.87%

	RDUS State -->
	  Interest payments to sales is high at 23.20%.
	  LT debt to equity of 6.56 is high.

	Zombie Score : 74.59
		Negative Sales        :    0.00
		Margins               :   35.00
		Available Cash to MC  :    0.00
		Interest Paid         :   23.20
		LT Debt to Equity     :   16.39
		Equity to MC          :    0.00
		OpsInc Growth 3Yr     :    0.00 : (0.00%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00

Rank : 41
 REPH
	Recro Pharma Inc : MALVERN, PA
	Healthcare, Biotechnology & Medical Research
	Employees     :          255
	OpInc per Emp : $   -625,882
	10Q Date      :  31-Mar-2019

	Market Cap        :        212.41 M
	Shares            :         21.92 M (Seq=    1.98% : QoQ=   14.04%)

	Sales 12m         :        301.30 M (Seq=    7.24% : QoQ=   59.42%)
	Ops Income 12m    :       -159.60 M (Seq=   26.85% : QoQ= -464.29%)
	Net Income 12m    :       -229.20 M (Seq=   13.17% : QoQ= -2,406.67%)
	Interest Paid 12m :         36.80 M (Seq=   18.18% : QoQ=   85.71%)

	Cash <- Ops 12m   :        -40.80 M (Seq=  -54.32% : QoQ=   15.54%)
	  CapEx 12m       :         11.80 M (Seq=  -53.23% : QoQ=   70.59%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :        -52.60 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :         59.50 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :         18.70 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :        -19.00 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :         -0.30 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :         94.60 M (Seq=   33.05% : QoQ=   19.29%)
	  Cash            :         46.00 M (Seq=   19.48% : QoQ=   -0.65%)
	  Acct Rx         :         21.30 M (Seq=   17.68% : QoQ=   39.22%)
	  ST Invest       :         12.00 M (Seq=    0.00% : QoQ=  140.00%)
	  Inventory       :         10.20 M (Seq=   -4.67% : QoQ=    2.00%)
	  Other           :          5.10 M (Seq=   30.77% : QoQ=   88.89%)
	Current Liabs     :         26.50 M (Seq=   -8.62% : QoQ=  -40.72%)
	  Acct Pay        :         10.50 M (Seq=  133.33% : QoQ=  144.19%)
	  ST Debt         :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :         16.00 M (Seq=  -34.69% : QoQ=  -60.30%)
	Working Capital   :         68.10 M (Ratio=3.57)
	WC + FCF          :         15.50 M

	Sharehldr Equity  :        -19.00 M (Seq=    2.56% : QoQ= -177.24%)
	Tangible Assets   :        142.90 M (Seq=   22.35% : QoQ=    3.70%)
	LT Debt           :        105.90 M (Seq=   64.95% : QoQ=   96.11%)
	LT Debt Tan Asset :          0.74

	Last Price          :       10.05 : (52wkHi= 10.69 %offHigh=5%)
	PE                  :      275.00
	Op Margin           :      -52.97%
	Net Margin          :      -76.07%
	ROE                 :        0.00%
	Interest % of sales :       12.21%
	Q0 Est Growth       :      105.56%
	Y1 Est Growth       :      250.72%

	REPH State -->
	  Shareholders have no equity.

	Zombie Score : 74.06
		Negative Sales        :    0.00
		Margins               :   12.90
		Available Cash to MC  :    0.00
		Interest Paid         :   12.21
		LT Debt to Equity     :    5.00
		Equity to MC          :    8.94
		OpsInc Growth 3Yr     :   35.00 : (-97.90%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00

Rank : 42
 MAT
	Mattel Inc : EL SEGUNDO, CA
	Consumer Cyclicals, Toys & Children's Products, SP400
	Employees     :       27,000
	OpInc per Emp : $     -5,592
	10Q Date      :  31-Mar-2019

	Market Cap        :      4,006.20 M
	Shares            :        345.85 M (Seq=    0.04% : QoQ=    0.41%)

	Sales 12m         :     19,341.30 M (Seq=   -0.43% : QoQ=  -21.23%)
	Ops Income 12m    :       -151.00 M (Seq=   61.56% : QoQ= -116.81%)
	Net Income 12m    :     -1,671.70 M (Seq=   24.01% : QoQ= -210.19%)
	Interest Paid 12m :        570.00 M (Seq=    3.24% : QoQ=  120.16%)

	Cash <- Ops 12m   :         53.60 M (Seq= -127.38% : QoQ=   29.56%)
	  CapEx 12m       :         64.40 M (Seq=  -50.69% : QoQ=  -49.05%)
	  Dividends 12m   :      1,364.18 M (Yield=34.05%)
	    FCF 12m       :     -1,374.98 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :        -38.00 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :         15.60 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :       -149.10 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :       -133.50 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :      1,895.10 M (Seq=  -19.44% : QoQ=  -14.70%)
	  Cash            :        380.10 M (Seq=  -36.06% : QoQ=  -27.83%)
	  Acct Rx         :        624.50 M (Seq=  -35.63% : QoQ=   -7.63%)
	  ST Invest       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Inventory       :        615.80 M (Seq=   13.43% : QoQ=   -9.13%)
	  Other           :        274.70 M (Seq=   12.12% : QoQ=  -19.47%)
	Current Liabs     :      1,006.30 M (Seq=  -19.66% : QoQ=    1.93%)
	  Acct Pay        :        324.90 M (Seq=  -39.61% : QoQ=  -18.45%)
	  ST Debt         :          4.20 M (Seq=  -98.47% : QoQ=  -98.32%)
	  Other           :        681.30 M (Seq=   -4.11% : QoQ=   15.71%)
	Working Capital   :        888.80 M (Ratio=1.88)
	WC + FCF          :       -486.18 M

	Sharehldr Equity  :        518.50 M (Seq=  -22.55% : QoQ=  -47.23%)
	Tangible Assets   :      3,113.10 M (Seq=   -4.78% : QoQ=   -4.85%)
	LT Debt           :      2,853.50 M (Seq=    0.06% : QoQ=   -0.64%)
	LT Debt to Equity :          5.50

	Last Price          :       11.60 : (52wkHi= 17.47 %offHigh=33%)
	PE                  :      275.00
	Op Margin           :       -0.78%
	Net Margin          :       -8.64%
	ROE                 :     -322.41%
	Interest % of sales :        2.95%
	Q0 Est Growth       :      168.58%
	Y1 Est Growth       :      217.54%

	MAT State -->
	  Free Cash Flow plus Working Capital is negative (-486.18) with dividend paid 1364.18.
	  LT debt to equity of 5.50 is high.

	Zombie Score : 73.48
		Negative Sales        :   21.23
		Margins               :    0.94
		Available Cash to MC  :    0.00
		Interest Paid         :    2.95
		LT Debt to Equity     :   13.76
		Equity to MC          :    0.00
		OpsInc Growth 3Yr     :   34.60 : (-34.60%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00

Rank : 43
 WYND
	Wyndham Destinations Inc : ORLANDO, FL
	Consumer Cyclicals, Hotels, Motels & Cruise Lines, SP400
	Employees     :       24,500
	OpInc per Emp : $     88,530
	10Q Date      :  31-Mar-2019

	Market Cap        :      4,404.07 M
	Shares            :         94.40 M (Seq=   -2.18% : QoQ=   -5.69%)
	Share Change 12m  :         -5.70 M (Buyback Est= $231.13M)

	Sales 12m         :     15,371.00 M (Seq=    0.28% : QoQ=  -19.19%)
	Ops Income 12m    :      2,169.00 M (Seq=    7.07% : QoQ=  -40.11%)
	Net Income 12m    :      2,855.00 M (Seq=    6.85% : QoQ=   17.32%)
	Interest Paid 12m :        623.00 M (Seq=   -2.94% : QoQ=   35.25%)

	Cash <- Ops 12m   :        461.00 M (Seq=   74.71% : QoQ=   14.29%)
	  CapEx 12m       :         91.00 M (Seq=  -44.44% : QoQ=  -28.57%)
	  Dividends 12m   :        769.27 M (Yield=17.47%)
	    FCF 12m       :       -399.27 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :        143.00 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :        604.00 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :       -737.00 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :       -133.00 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :      4,948.00 M (Seq=   -5.07% : QoQ=   34.38%)
	  Cash            :        217.00 M (Seq=   -0.46% : QoQ=  -25.43%)
	  Acct Rx         :      3,157.00 M (Seq=   -0.03% : QoQ=  339.69%)
	  ST Invest       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Inventory       :      1,213.00 M (Seq=   -0.90% : QoQ=  259.94%)
	  Other           :        361.00 M (Seq=  -41.01% : QoQ=  -84.55%)
	Current Liabs     :      1,502.00 M (Seq=   -5.42% : QoQ=  -51.53%)
	  Acct Pay        :         79.00 M (Seq=   19.70% : QoQ=  -67.76%)
	  ST Debt         :          0.00 M (Seq=    0.00% : QoQ= -100.00%)
	  Other           :      1,423.00 M (Seq=   -6.50% : QoQ=  -44.52%)
	Working Capital   :      3,446.00 M (Ratio=3.29)
	WC + FCF          :      3,046.72 M

	Sharehldr Equity  :       -589.00 M (Seq=   -2.61% : QoQ= -191.32%)
	Tangible Assets   :      6,339.00 M (Seq=    3.46% : QoQ=  -27.00%)
	LT Debt           :      5,291.00 M (Seq=    1.01% : QoQ=  -11.40%)
	LT Debt Tan Asset :          0.83

	Last Price          :       45.17 : (52wkHi= 47.55 %offHigh=5%)
	PE                  :        4.00
	Op Margin           :       14.11%
	Net Margin          :       18.57%
	ROE                 :        0.00%
	Interest % of sales :        4.05%
	EPS Yield           :       25.02% ($11.30)
	Q0 Est Growth       :      300.00%
	Y1 Est Growth       :      300.00%

	WYND State -->
	  Shareholders have no equity.

	Zombie Score : 73.45
		Negative Sales        :   19.19
		Margins               :    0.00
		Available Cash to MC  :    0.00
		Interest Paid         :    4.05
		LT Debt to Equity     :    5.00
		Equity to MC          :   13.37
		OpsInc Growth 3Yr     :   17.60 : (-17.60%)
		Share Decline         :   14.24
		Price                 :    0.00
		Price % of 52wk High  :    0.00

Rank : 44
 XERS
	Xeris Pharmaceuticals Inc : CHICAGO, IL
	Healthcare, Biotechnology & Medical Research
	Employees     :          113
	OpInc per Emp : $ -1,523,893
	10Q Date      :  31-Mar-2019

	Market Cap        :        270.17 M
	Shares            :         23.56 M (Seq=   12.37% : QoQ=   19.38%)

	Sales 12m         :          7.70 M (Seq=    0.00% : QoQ=    0.00%)
	Ops Income 12m    :       -172.20 M (Seq=  -23.27% : QoQ=    0.00%)
	Net Income 12m    :       -173.40 M (Seq=  -22.30% : QoQ=    0.00%)
	Interest Paid 12m :          5.90 M (Seq=   36.00% : QoQ=    0.00%)

	Cash <- Ops 12m   :        -69.60 M (Seq=  -15.85% : QoQ= -171.79%)
	  CapEx 12m       :          1.50 M (Seq=  -33.33% : QoQ=  -33.33%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :        -71.10 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :        160.10 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :         90.50 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :        -86.60 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :          3.90 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        153.40 M (Seq=   30.11% : QoQ=  156.52%)
	  Cash            :         62.00 M (Seq=   35.67% : QoQ=    6.71%)
	  Acct Rx         :          3.60 M (Seq=   24.14% : QoQ= 1,100.00%)
	  ST Invest       :         85.70 M (Seq=   28.10% : QoQ=    0.00%)
	  Inventory       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :          2.10 M (Seq=  -12.50% : QoQ=   50.00%)
	Current Liabs     :         13.40 M (Seq=   31.37% : QoQ=   45.65%)
	  Acct Pay        :          1.40 M (Seq=   55.56% : QoQ=   75.00%)
	  ST Debt         :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :         12.00 M (Seq=   29.03% : QoQ=   44.58%)
	Working Capital   :        140.00 M (Ratio=11.45)
	WC + FCF          :         68.90 M

	Sharehldr Equity  :        107.10 M (Seq=   42.04% : QoQ=  254.32%)
	Tangible Assets   :        161.00 M (Seq=   34.17% : QoQ=  161.36%)
	LT Debt           :         32.10 M (Seq=    0.63% : QoQ=   77.35%)
	LT Debt to Equity :          0.30

	Last Price          :       12.57 : (52wkHi= 27.98 %offHigh=55%)
	PE                  :      275.00
	Op Margin           :   -2,236.36%
	Net Margin          :   -2,251.95%
	ROE                 :     -161.90%
	Interest % of sales :       76.62%
	Q0 Est Growth       :     -164.18%
	Y1 Est Growth       :      -82.72%

	XERS State -->
	  Interest payments to sales is high at 76.62%.

	Zombie Score : 72.54
		Negative Sales        :    0.00
		Margins               :   35.00
		Available Cash to MC  :    0.00
		Interest Paid         :   35.00
		LT Debt to Equity     :    0.00
		Equity to MC          :  -10.00
		OpsInc Growth 3Yr     :    0.00 : (0.00%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    2.54
		Earnings weakness     :   10.00

Rank : 45
 NTRA
	Natera Inc : SAN CARLOS, CA
	Healthcare, Medical Equipment, Supplies & Distribution
	Employees     :          975
	OpInc per Emp : $   -478,769
	10Q Date      :  31-Mar-2019

	Market Cap        :      1,587.32 M
	Shares            :         62.83 M (Seq=    1.33% : QoQ=   16.07%)

	Sales 12m         :        941.90 M (Seq=    1.71% : QoQ=   37.66%)
	Ops Income 12m    :       -466.80 M (Seq=   -1.05% : QoQ=  -93.65%)
	Net Income 12m    :       -495.50 M (Seq=   -0.94% : QoQ=  -84.07%)
	Interest Paid 12m :         26.00 M (Seq=    2.86% : QoQ=  208.57%)

	Cash <- Ops 12m   :       -103.40 M (Seq= -148.44% : QoQ= -3,280.00%)
	  CapEx 12m       :          4.00 M (Seq=  -52.38% : QoQ=   11.11%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :       -107.40 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :        115.70 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :         12.30 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :        -17.30 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :         -5.00 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        208.10 M (Seq=  -13.47% : QoQ=   10.99%)
	  Cash            :         34.30 M (Seq=  -26.08% : QoQ=    1.78%)
	  Acct Rx         :         60.30 M (Seq=   -3.05% : QoQ=   19.88%)
	  ST Invest       :         93.80 M (Seq=  -12.74% : QoQ=   17.25%)
	  Inventory       :         13.70 M (Seq=    0.74% : QoQ=   15.13%)
	  Other           :          6.00 M (Seq=  -44.44% : QoQ=  -48.28%)
	Current Liabs     :        112.70 M (Seq=   -1.14% : QoQ=    7.95%)
	  Acct Pay        :          8.90 M (Seq=  -39.04% : QoQ=    3.49%)
	  ST Debt         :         50.20 M (Seq=    0.00% : QoQ=    0.20%)
	  Other           :         53.60 M (Seq=    8.94% : QoQ=   17.29%)
	Working Capital   :         95.40 M (Ratio=1.85)
	WC + FCF          :        -12.00 M

	Sharehldr Equity  :          5.00 M (Seq=  -84.47% : QoQ=  228.21%)
	Tangible Assets   :        261.40 M (Seq=   -2.54% : QoQ=   19.52%)
	LT Debt           :         73.40 M (Seq=    0.00% : QoQ=    0.41%)
	LT Debt to Equity :         14.68

	Last Price          :       26.46 : (52wkHi= 29.62 %offHigh=10%)
	PE                  :      275.00
	Op Margin           :      -49.56%
	Net Margin          :      -52.61%
	ROE                 :   -9,910.00%
	Interest % of sales :        2.76%
	Q0 Est Growth       :       14.83%
	Y1 Est Growth       :        7.18%

	NTRA State -->
	  Free Cash Flow plus Working Capital is negative (-12.00)
	  Running company with Financing. Cash from Financing greater than FCF plus Working Capital.
	  LT debt to equity of 14.68 is high.

	Zombie Score : 72.37
		Negative Sales        :    0.00
		Margins               :   10.22
		Available Cash to MC  :    0.50
		Interest Paid         :    2.76
		LT Debt to Equity     :   35.00
		Equity to MC          :   -0.31
		OpsInc Growth 3Yr     :   24.20 : (-24.20%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00

Rank : 46
 GLIBA
	GCI Liberty Inc : ENGLEWOOD, CO
	Telecommunications Services, Telecommunication Services - Integrated
	Employees     :        2,270
	OpInc per Emp : $   -190,044
	10Q Date      :  31-Mar-2019

	Market Cap        :      6,812.01 M
	Shares            :        104.84 M (Seq=   -3.48% : QoQ=   -2.69%)
	Share Change 12m  :         -2.89 M (Buyback Est= $148.06M)

	Sales 12m         :      3,489.10 M (Seq=   21.15% : QoQ=   -8.40%)
	Ops Income 12m    :       -431.40 M (Seq=   -5.78% : QoQ= -552.81%)
	Net Income 12m    :       -925.30 M (Seq=   97.24% : QoQ=    7.31%)
	Interest Paid 12m :        445.20 M (Seq=   24.64% : QoQ=   74.12%)

	Cash <- Ops 12m   :        125.60 M (Seq=  -52.37% : QoQ=  197.69%)
	  CapEx 12m       :        168.00 M (Seq=  -10.89% : QoQ=  516.92%)
	  Dividends 12m   :         93.81 M (Yield=1.38%)
	    FCF 12m       :       -136.21 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :        107.00 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :        232.60 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :       -213.10 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :         19.50 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        669.40 M (Seq=  -10.83% : QoQ=   -5.06%)
	  Cash            :        422.40 M (Seq=  -14.02% : QoQ=    4.89%)
	  Acct Rx         :        212.60 M (Seq=   -3.10% : QoQ=  -19.56%)
	  ST Invest       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Inventory       :          0.00 M (Seq=    0.00% : QoQ= -100.00%)
	  Other           :         34.30 M (Seq=  -14.46% : QoQ=   -9.97%)
	Current Liabs     :      1,173.00 M (Seq=    8.53% : QoQ=  181.29%)
	  Acct Pay        :         80.70 M (Seq=  -19.54% : QoQ=  178.28%)
	  ST Debt         :        913.10 M (Seq=    1.37% : QoQ=    0.00%)
	  Other           :        179.20 M (Seq=  124.84% : QoQ=  -53.81%)
	Working Capital   :       -503.60 M (Ratio=0.57)
	WC + FCF          :       -639.81 M

	Sharehldr Equity  :      4,939.50 M (Seq=   14.95% : QoQ=   -3.32%)
	Tangible Assets   :      8,042.30 M (Seq=   17.00% : QoQ=    6.84%)
	LT Debt           :      2,337.60 M (Seq=    2.32% : QoQ=  -15.96%)
	LT Debt to Equity :          0.47

	Last Price          :       63.54 : (52wkHi= 63.65 %offHigh=0%)
	PE                  :      275.00
	Op Margin           :      -12.36%
	Net Margin          :      -26.52%
	ROE                 :      -18.73%
	Interest % of sales :       12.76%
	Q0 Est Growth       :      250.76%
	Y1 Est Growth       :      300.00%

	GLIBA State -->
	  Free Cash Flow plus Working Capital is negative (-639.81) with dividend paid 93.81.

	Zombie Score : 72.31
		Negative Sales        :    8.40
		Margins               :    3.89
		Available Cash to MC  :    5.55
		Interest Paid         :   12.76
		LT Debt to Equity     :    0.00
		Equity to MC          :    0.00
		OpsInc Growth 3Yr     :   35.00 : (-84.50%)
		Share Decline         :    6.71
		Price                 :    0.00
		Price % of 52wk High  :    0.00

Rank : 47
 YUM
	Yum! Brands, Inc. : LOUISVILLE, KY
	Consumer Cyclicals, Restaurants & Bars, SP500
	Employees     :       34,000
	OpInc per Emp : $    262,205
	10Q Date      :  31-Mar-2019

	Market Cap        :     35,041.93 M
	Shares            :        308.00 M (Seq=   -1.60% : QoQ=   -7.23%)
	Share Change 12m  :        -24.00 M (Buyback Est= $2,268.00M)

	Sales 12m         :     23,493.00 M (Seq=   -2.06% : QoQ=  -13.20%)
	Ops Income 12m    :      8,915.00 M (Seq=   -5.23% : QoQ=   51.74%)
	Net Income 12m    :      5,896.00 M (Seq=  -11.09% : QoQ=    7.28%)
	Interest Paid 12m :      1,453.00 M (Seq=    4.86% : QoQ=  228.48%)

	Cash <- Ops 12m   :      1,287.00 M (Seq=  -21.05% : QoQ=   58.73%)
	  CapEx 12m       :        236.00 M (Seq=  -49.43% : QoQ=    4.76%)
	  Dividends 12m   :      1,903.97 M (Yield=5.43%)
	    FCF 12m       :       -852.97 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :     -1,922.00 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :       -635.00 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :        115.00 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :       -520.00 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :      1,186.00 M (Seq=   -1.74% : QoQ=  -37.22%)
	  Cash            :        278.00 M (Seq=   -4.79% : QoQ=  -71.69%)
	  Acct Rx         :        543.00 M (Seq=   -9.05% : QoQ=    8.38%)
	  ST Invest       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Inventory       :          0.00 M (Seq=    0.00% : QoQ= -100.00%)
	  Other           :        365.00 M (Seq=   14.78% : QoQ=  -10.10%)
	Current Liabs     :      1,327.00 M (Seq=    2.00% : QoQ=   19.66%)
	  Acct Pay        :        840.00 M (Seq=   -7.79% : QoQ=   -9.09%)
	  ST Debt         :        338.00 M (Seq=    5.30% : QoQ=  454.10%)
	  Other           :        149.00 M (Seq=  115.94% : QoQ=   20.16%)
	Working Capital   :       -141.00 M (Ratio=0.89)
	WC + FCF          :       -993.97 M

	Sharehldr Equity  :     -7,904.00 M (Seq=    0.28% : QoQ=  -17.03%)
	Tangible Assets   :      3,972.00 M (Seq=   18.11% : QoQ=   -5.81%)
	LT Debt           :      9,736.00 M (Seq=   -0.15% : QoQ=    3.37%)
	LT Debt Tan Asset :          2.45

	Last Price          :      110.98 : (52wkHi= 111.32 %offHigh=0%)
	PE                  :        6.91
	Op Margin           :       37.95%
	Net Margin          :       25.10%
	ROE                 :        0.00%
	Interest % of sales :        6.18%
	EPS Yield           :       14.46% ($16.05)
	Q0 Est Growth       :     -102.80%
	Y1 Est Growth       :      -49.87%

	YUM State -->
	  Free Cash Flow plus Working Capital is negative (-993.97) with dividend paid 1903.97.
	  Shareholders have no equity.

	Zombie Score : 71.94
		Negative Sales        :   13.20
		Margins               :    0.00
		Available Cash to MC  :    0.00
		Interest Paid         :    6.18
		LT Debt to Equity     :    5.00
		Equity to MC          :   22.56
		OpsInc Growth 3Yr     :    0.00 : (17.00%)
		Share Decline         :   15.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00
		Earnings weakness     :   10.00

Rank : 48
 AKTS
	Akoustis Technologies Inc : HUNTERSVILLE, NC
	Technology, Semiconductors
	Employees     :           69
	OpInc per Emp : $   -923,188
	10Q Date      :  31-Mar-2019

	Market Cap        :        160.56 M
	Shares            :         29.96 M (Seq=    7.56% : QoQ=   34.44%)

	Sales 12m         :          2.80 M (Seq=   -8.33% : QoQ=    0.00%)
	Ops Income 12m    :        -63.70 M (Seq=  -24.22% : QoQ= -610.26%)
	Net Income 12m    :        -67.10 M (Seq=  -39.17% : QoQ= -716.22%)
	Interest Paid 12m :          2.60 M (Seq=  666.67% : QoQ=    0.00%)

	Cash <- Ops 12m   :        -16.50 M (Seq=  -28.95% : QoQ=  -11.36%)
	  CapEx 12m       :          6.10 M (Seq=  285.71% : QoQ=  237.50%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :        -22.60 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :         50.80 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :         34.30 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :         -6.20 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :         28.10 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :         35.80 M (Seq=  -17.51% : QoQ=  390.41%)
	  Cash            :         34.60 M (Seq=  -17.81% : QoQ=  432.31%)
	  Acct Rx         :          0.20 M (Seq=  -33.33% : QoQ=  -60.00%)
	  ST Invest       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Inventory       :          0.10 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :          0.90 M (Seq=    0.00% : QoQ=  200.00%)
	Current Liabs     :          2.80 M (Seq=    7.69% : QoQ=   40.00%)
	  Acct Pay        :          0.30 M (Seq=  -62.50% : QoQ=  200.00%)
	  ST Debt         :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :          2.50 M (Seq=   47.06% : QoQ=   31.58%)
	Working Capital   :         33.00 M (Ratio=12.79)
	WC + FCF          :         10.40 M

	Sharehldr Equity  :         29.70 M (Seq=  -18.85% : QoQ=   77.84%)
	Tangible Assets   :         51.80 M (Seq=   -9.60% : QoQ=  161.62%)
	LT Debt           :         19.10 M (Seq=   12.35% : QoQ=    0.00%)
	LT Debt to Equity :          0.64

	Last Price          :        6.28 : (52wkHi= 9.37 %offHigh=32%)
	PE                  :      275.00
	Op Margin           :   -2,275.00%
	Net Margin          :   -2,396.43%
	ROE                 :     -225.93%
	Interest % of sales :       92.86%
	Q0 Est Growth       :      -66.67%
	Y1 Est Growth       :      -27.14%

	AKTS State -->
	  Interest payments to sales is high at 92.86%.

	Zombie Score : 70.00
		Negative Sales        :    0.00
		Margins               :   35.00
		Available Cash to MC  :    0.00
		Interest Paid         :   35.00
		LT Debt to Equity     :    0.00
		Equity to MC          :  -10.00
		OpsInc Growth 3Yr     :   35.00 : (-79.20%)
		Share Decline         :    0.00
		Price                 :  -35.00
		Price % of 52wk High  :    0.00
		Earnings weakness     :   10.00

Rank : 49
 ICPT
	Intercept Pharmaceuticals Inc : NEW YORK, NY
	Healthcare, Biotechnology & Medical Research
	Employees     :          330
	OpInc per Emp : $ -3,992,424
	10Q Date      :  31-Mar-2019

	Market Cap        :      2,191.93 M
	Shares            :         29.76 M (Seq=    0.25% : QoQ=   17.59%)

	Sales 12m         :        531.90 M (Seq=    9.07% : QoQ= 6,903.57%)
	Ops Income 12m    :     -1,317.50 M (Seq=   -2.94% : QoQ=  -28.23%)
	Net Income 12m    :     -1,400.30 M (Seq=   -2.81% : QoQ=  -40.42%)
	Interest Paid 12m :        104.90 M (Seq=    1.31% : QoQ=    0.00%)

	Cash <- Ops 12m   :       -235.30 M (Seq=  -57.95% : QoQ=    6.19%)
	  CapEx 12m       :          0.80 M (Seq=  600.00% : QoQ=  600.00%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :       -236.10 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :        263.30 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :         28.00 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :        -20.40 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :          7.60 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        402.80 M (Seq=  -16.50% : QoQ=   10.72%)
	  Cash            :         54.70 M (Seq=   26.62% : QoQ=   11.86%)
	  Acct Rx         :         29.40 M (Seq=   14.40% : QoQ=   73.96%)
	  ST Invest       :        298.80 M (Seq=  -23.95% : QoQ=    7.79%)
	  Inventory       :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :         19.80 M (Seq=   -3.88% : QoQ=   -4.81%)
	Current Liabs     :        108.30 M (Seq=   -5.17% : QoQ=   36.40%)
	  Acct Pay        :         18.60 M (Seq=   57.63% : QoQ=   37.78%)
	  ST Debt         :          0.00 M (Seq=    0.00% : QoQ=    0.00%)
	  Other           :         89.80 M (Seq=  -12.30% : QoQ=   36.27%)
	Working Capital   :        294.50 M (Ratio=3.72)
	WC + FCF          :         58.40 M

	Sharehldr Equity  :        -55.00 M (Seq= -387.96% : QoQ=   -5.16%)
	Tangible Assets   :        438.30 M (Seq=  -13.92% : QoQ=   11.30%)
	LT Debt           :        375.40 M (Seq=    1.10% : QoQ=    4.45%)
	LT Debt Tan Asset :          0.86

	Last Price          :       74.14 : (52wkHi= 133.74 %offHigh=44%)
	PE                  :      275.00
	Op Margin           :     -247.70%
	Net Margin          :     -263.26%
	ROE                 :        0.00%
	Interest % of sales :       19.72%
	Q0 Est Growth       :       60.30%
	Y1 Est Growth       :        6.32%

	ICPT State -->
	  Interest payments to sales is high at 19.72%.
	  Shareholders have no equity.

	Zombie Score : 69.83
		Negative Sales        :    0.00
		Margins               :   35.00
		Available Cash to MC  :    0.00
		Interest Paid         :   19.72
		LT Debt to Equity     :    5.00
		Equity to MC          :    2.51
		OpsInc Growth 3Yr     :    7.60 : (-7.60%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00

Rank : 50
 CVNA
	Carvana Co : TEMPE, AZ
	Consumer Cyclicals, Retailers - Auto Vehicles, Parts & Service
	Employees     :        3,879
	OpInc per Emp : $   -204,485
	10Q Date      :  31-Mar-2019

	Market Cap        :      2,421.50 M
	Shares            :         41.35 M (Seq=    4.98% : QoQ=  125.40%)

	Sales 12m         :      5,529.80 M (Seq=   20.19% : QoQ= 1,702.38%)
	Ops Income 12m    :       -793.20 M (Seq=  -11.79% : QoQ= -672.48%)
	Net Income 12m    :       -228.00 M (Seq=  -27.93% : QoQ= -2,052.50%)
	Interest Paid 12m :         73.40 M (Seq=   48.40% : QoQ= 2,550.00%)

	Cash <- Ops 12m   :       -497.40 M (Seq=  -42.52% : QoQ=  -63.24%)
	  CapEx 12m       :        158.80 M (Seq=   18.68% : QoQ=   54.29%)
	  Dividends 12m   :          0.00 M
	    FCF 12m       :       -656.20 M [Cash from Operations - CapEx - Dividends]
	Cash <- Fin 12m   :        630.00 M [Movement of cash between a firm and its owners/creditors : borrowing, debt repayment, dividend paid, equity financing.]
	  Net Cash 12m    :        132.60 M [Cash from Ops + Cash from Financing]
	Cash <- Inv 12m   :       -165.50 M [Purchases and sales of long-term assets such as plant and machinery - assumed infrequent.]
	  Cash Flow 12m   :        -32.90 M [Cash from Ops + Cash from Financing + Cash from Investing]

	Current Assets    :        876.80 M (Seq=   32.27% : QoQ=   61.98%)
	  Cash            :         85.30 M (Seq=    8.11% : QoQ=  -29.79%)
	  Acct Rx         :         38.20 M (Seq=   15.41% : QoQ=   81.90%)
	  ST Invest       :        151.20 M (Seq=   43.73% : QoQ=  141.92%)
	  Inventory       :        525.70 M (Seq=   27.54% : QoQ=   75.35%)
	  Other           :         76.40 M (Seq=  128.74% : QoQ=  108.74%)
	Current Liabs     :        630.00 M (Seq=   91.20% : QoQ=   50.07%)
	  Acct Pay        :         61.30 M (Seq=   51.73% : QoQ=  285.53%)
	  ST Debt         :        450.10 M (Seq=  116.29% : QoQ=   26.90%)
	  Other           :        118.60 M (Seq=   46.42% : QoQ=  141.06%)
	Working Capital   :        246.80 M (Ratio=1.39)
	WC + FCF          :       -409.40 M

	Sharehldr Equity  :         54.80 M (Seq=  -25.34% : QoQ=  151.38%)
	Tangible Assets   :      1,320.60 M (Seq=   35.75% : QoQ=   83.24%)
	LT Debt           :        479.00 M (Seq=   12.63% : QoQ=  617.07%)
	LT Debt to Equity :          8.74

	Last Price          :       67.65 : (52wkHi= 76.85 %offHigh=11%)
	PE                  :      275.00
	Op Margin           :      -14.34%
	Net Margin          :       -4.12%
	ROE                 :     -416.06%
	Interest % of sales :        1.33%
	Q0 Est Growth       :       64.29%
	Y1 Est Growth       :       52.21%

	CVNA State -->
	  Free Cash Flow plus Working Capital is negative (-409.40)
	  Running company with Financing. Cash from Financing greater than FCF plus Working Capital.
	  LT debt to equity of 8.74 is high.

	Zombie Score : 68.11
		Negative Sales        :    0.00
		Margins               :    1.85
		Available Cash to MC  :   10.35
		Interest Paid         :    1.33
		LT Debt to Equity     :   21.85
		Equity to MC          :   -2.26
		OpsInc Growth 3Yr     :   35.00 : (-90.40%)
		Share Decline         :    0.00
		Price                 :    0.00
		Price % of 52wk High  :    0.00
